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PARATRANSGENIC CONTROL OF PIERCE'S DISEASE

by

ARINDER K. ARORA
M.S., Cell Molecular and Developmental Biology, University of California, 2010
Ph.D., Biology, University of New Mexico, 2015

Abstract of Dissertation
Pierce's Disease (PD) is a deadly grapevine disease, which is caused by a Gram
negative bacterium, Xylella fastidiosa and transmitted by leafhoppers commonly known
as sharpshooters, including the glassy-winged sharpshooter (GWSS, Homalodisca
vitripennis). We developed paratransgenic control of PD using a commensal bacterium
Pantoea agglomerans E325. The GWSSs acquired enhanced green fluorescent (EGFP)expressing P. agglomerans from an artificial feeding system and the bacteria persisted
within the insect foregut for two weeks. P. agglomerans was selected as the
paratransgenic control agent based on its persistence within the sharpshooter foregut, a
niche also inhabited by X. fastidiosa. P. agglomerans lines secreting two antimicrobial
peptides (AMPs), melittin and scorpine-like molecule (SLM), were generated to
accomplish transmission blockage. These AMPs were selected after testing their toxicity
to P. agglomerans and X. fastidiosa. Our experiments indicated that both melittin and
SLM are more toxic to X. fastidiosa compared to P. agglomerans. Paratransgenic
GWSSs, which have acquired an AMP-expressing P. agglomerans prior to X. fastidiosa

vi

acquisition, displayed a lower competence to acquire the pathogen in comparison to
control insects. These paratransgenic sharpshooters failed to transmit X. fastidiosa to
naive grapevines. This is the first instance, wherein paratransgenesis has been
demonstrated to block PD transmission. We established melittin and SLM expression
within the paratransgenic sharpshooters via Western blot and confirmed that transmission
blockage was as a direct result of AMPs expressed by P. agglomerans within the insect
gut.
Subsequently, we also engineered calcium-alginate based microparticles to reduce
environmental contamination during field application of genetically modified bacteria.
The insects were able to acquire the bacteria from plants painted with P. agglomerans containing micropaticles. Amongst the tested microparticles (engineered using 1%, 2%
and 3% alginate) the ones engineered using 1% alginate resulted in the highest P.
agglomerans acquisition (51.8%) by the sharpshooters. These microparticles will be a
means to take the technology from a lab to the field.
Active molecules, which target specifically the pathogen only, have an advantage
that they won't affect the natural flora and fauna. Keeping this in mind we have
engineered antibodies that bind to X. fastidiosa surface protein mopB using ribosomal
display methodology. These antibodies bind specifically to X. fastidiosa surface protein.
In the future we can express these antibodies individually or as chimeras in combination
with AMPs via P. agglomerans. Expression of two active molecules will also decrease
the rate of resistance development and will increase the useful life span of this technology
in the field.
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Chapter 1: Introduction
Arthropod transmitted pathogens and parasites take a huge toll on economics as
well as on human health by causing diseases in humans, livestock and plants. Malaria
killed 627,000 people in 2012 and caused losses of USD 12 billion (CDC:
http://www.cdc.gov/malaria/malaria_worldwide/impact.html). Ten million individuals
get infected with Chagas disease and a whopping $ 7 billion are lost to this disease every
year (Lee et al., 2013). Nagana, a disease of livestock, kills 3 million cattle every year
(Enyaru et al., 2014). Vector borne plant diseases destroy the agricultural crops and the
damages caused by these diseases run into billions of dollars. According to an estimate
by Hodges and Spreen (2012) citrus greening caused a loss of $1.709 billion over a
period of 5 years (from 2006/07-2010/11). These examples show that vector borne
diseases are a big threat to human population as well as to the global food security.
Spread of these diseases is kept under check by suppressing vector populations using
chemical insecticides. Though chemical insecticides give a quick kill, they cause
environmental contamination and their prolonged use results in resistance development in
the target insects (Pimentel, 2005). Biological control using natural enemies is
environmentally friendly, but does not always curb insect populations sufficiently to
impact disease transmission. Ineffectiveness of biological control and concerns over
insecticide use demand development of novel methods and strategies to control disease
spread. Paratransgenesis is one such strategy that can be used to control different vector
borne diseases.
Paratransgenesis, a "Trojan Horse" strategy, intends to block disease transmission
by delivering anti-pathogen molecules within the vector-gut using genetically modified
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symbionts or commensal bacteria. In this approach, a symbiont is genetically modified to
produce anti-pathogen molecules after its isolation from the vector gut. The antipathogen molecules-expressing symbiont is then reintroduced into the vector gut. The

Figure 1: Paratransgenic control of Chagas disease (Conte, 1997)

paratransgenic vectors carrying genetically modified symbiont lose their ability to
transmit the disease owing to presence of pathogen interfering molecules.
Durvasula et al. (1997) pioneered the paratransgenesis approach and
demonstrated its applicability in blocking Chagas disease (Figure 1). Chagas disease is a
human ailment caused by the parasite, Trypanosoma cruzi, an infection transmitted by
bugs of the family Triatominae. Rhodnius prolixus is one of the important Triatomine
bugs that carries T. cruzi in its hindgut and transmits the parasite to human. Durvasuala et
al. (1997) identified a R. prolixus bacterial symbiont Rhodococcus rhodnii as a
paratransgenic control agent. They isolated and genetically modified the symbiont to
produce an antimicrobial peptide (AMP) - cecropin A. By introducing the genetically
2

modified R. rhodnii into the insect gut they generated paratransgenic R. prolixus. They
reported that thus generated paratransgenic vectors were refractory to T. cruzi acquisition
and 5 out of 7 paratransgenic insects were free of T. cruzi.
In 2012, paratransgenic mosquitoes were generated using genetically modified
Pantoea agglomerans, which inhabits the mosquito midgut. Wang et al. (2012)
engineered eight P. agglomerans lines each expressing one of these eight molecules - (i)
two copies of the 12-aa SM1 peptide [(SM1)2], a molecule that binds to mosquito midgut
and blocks ookinete invasion; (ii) a mutant phospholipase mPLA2, which inhibits
ookinete invasion into hemolymph; (iii) pbs21scFv-Shiva1 -a single chain monoclonal
antibody (scFv) targeting the Plasmodium berghei major ookinete surface and lytic
peptide Shiva1 chimera; (iv) a chitinase propeptide (Pro) that inhibits the chitinase
enzyme; (v) Shiva1 - a synthetic antiparasitic peptide; (vi) scorpine, an antimicrobial
peptide from Pandinus imperator (vii) (EPIP)4 four copies of the Plasmodium enolase–
plasminogen interaction peptide that inhibits mosquito midgut invasion by preventing
plasminogen binding to the ookinete surface; and (viii) a fusion peptide composed of Pro
and EPIP (Pro:EPIP). They reported > 85% decrease in P. falciparum carriage by these
paratransgenic mosquitoes. These studies show that symbiotic/commensal bacteria can be
used to deliver antiparasitic/antipathogenic molecules within an insect gut to decease
parasite carriage by a vector.
Paratransgenesis has an advantage that the arthropod vectors themselves are not
genetically modified, which is a very tedious process in comparison to genetically
altering a bacterium. However, not every microbial symbiont can be used as a
paratransgenic control agent and a symbiotic bacterium has to meet certain requirements
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before it can be used as a paratransgenic control agent. Beard et al. (2002) listed these
criteria:
1. An appropriate symbiotic association must exist between the bacteria and the
vector.
2. Only culturable and genetically alterable symbionts can be used for
paratransgenic control of a disease.
3. Genetically modified symbionts should remain stable long enough to deliver antipathogenic molecules within the insect gut.
4. Fitness of the genetically modified symbionts should not be compromised.
5. Normal functions of the symbiont should not be affected by introduction of new
gene.
6. Anti-pathogen molecules released from the genetically modified symbionts
should interact effectively with the target pathogen to interfere with its life cycle.
7. A method must exist or should be developed for field application of genetically
modified symbionts.
We developed a paratransgenesis
strategy to control Pierce's Disease (PD) of
grapevine. PD is a devastating disease of grapes
and is a major threat to the $3.2 billion grape
Figure 2: Homalodisca vitripennis

industry of California (Hoemmen et al., 2013).
PD is caused by a Gram negative, rod shaped, nonflagellate and xylem-limited bacterium
- Xylella fastidiosa. X. fastidiosa is transmitted by several species of xylem feeding
leafhoppers commonly known as sharpshooters namely - the blue green sharpshooter
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(Graphocephala atropunctata), the green sharpshooter (Draeculacephala minerva), the
black winged sharpshooter (Oncometopia nigricans), the red sharpshooter (Xyphon
fulgida) and the glassy-winged sharpshooter (Homalodisca vitripennis) (Fig. 2) (Janes
and Obradovic, 2012). In addition to infecting grapevines, X. fastidiosa has been reported
to infect more than 150 plant species, including economically important plants such as
citrus, coffee, almond and alfalfa species. (Hopkins, 1989; Janes and Obradovic, 2012).

Xylella fastidiosa
PD was first documented by Newton Pierce in late 19th century (Pierce, 1892).
For almost a century, PD was misdiagnosed as a disease caused first by a virus and later
by a mycoplasma-like organism (MLO), until the bacterium was first cultured by Davis et
al. (1978). X. fastidiosa inhabits the xylem vessels of the grapevines and other plants.
Xylem vessels are groups of small chambers, which are joined by pit membrane. These
conduits carry water and minerals from the plant roots to the leaves. After entering into
xylem vessels X. fastidiosa multiplies and
forms biofilms. The bacteria moves
basipetally as well as acropetally
colonizing other parts of infected plants.
Pit membranes, which join the vessels, are
Figure 3: Plant showing PD symptoms

made up of pectins and other

polysaccharides and X. fastidiosa digests the membranes using enzymes such as
polygalatouronase (PG) to enter into new vessels (Roper et al., 2007).
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Xylella biofilms interfere with water movement and result in water-stress like
symptoms such as chlorosis, followed by tip necrosis (Fig. 3). Later the leaves become
brown and fall down leaving the petioles behind, also known as match stick symptoms.
The infected plant remains stunted and produces shriveled berries. The wood matures
irregularly and the plant dies within 1-5 years after the infection (Janes and Obradovic,
2012).
Though X. fastidiosa colonizes the xylem vessels, it rarely clogs all the vessels.
Newman et al. (2003) reported that even in highly symptomatic grape plants only 10-15
% of xylem vessels were completely clogged and amongst different tissues, petioles had
the highest percent of clogged vessels.
Biofilm formation, quorum sensing, movement of bacteria and ability of X.
fastidiosa to break down the pit membrane have been implicated in disease development.
X. fastidiosa produces diffusible signaling factor (DSF), a quorum sensing
molecule, which mediates cell to cell signaling and plays a role in biofilm formation.
DSF is encoded by a gene RpfF. X. fastidiosa RpfF mutants lack the ability to form a
biofilm. However, these mutants were found to be hypervirulent in grape plants
(Newman et al., 2004). This hypervirulence was attributed to both increased bacterial
movement as well as higher bacterial multiplication in the xylem vessels of the plant as
compared to wild type X. fastidiosa (Chatterjee et al., 2008).
Within the RpfF gene cluster, another gene RpfC is also present and its product
acts as a RpfF regulator. RpfC mutants hyperexpressed rpfF and in turn overproduce
DSF. These mutants were deficient in movement as compared to wild type X. fastidiosa
in the xylem vessels of grape plant and multiply at a lower rate as compared to wild type
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X. fastidiosa. Subsequently, RpfC mutants displayed a lower virulence in comparison to
the wild type X. fastidiosa as well as the RpfF mutants (Chatterjee et al., 2008).
Type IV pili located on the pole of X. fastidiosa cells are involved in twitching
motility and migration. The mutants lacking type IV pili have been reported to be
deficient in twitching motility (Meng et al., 2005). Basipetal movement (against the flow
of water) of these mutants in grape plants was significantly retarded compared to the wild
type, and the type IV pilli mutants showed hypovirulence.
Additionally, hemogluttin proteins hxfA and hxfB appear to have a role in
attachment and biofilms formation. The mutants lacking hxfA and hxfB expression were
found to be hypervirulent because of their reduced binding to the vessel walls, which in
turn caused an increased and faster spread of the bacteria inside the xylem vessels of the
plant (Guilhabert and Kirckpatrick, 2005).
As mentioned earlier X. fastidiosa produces polyglactouronase (PG) to break
down pit membrane. Roper et al. (2007) generated X. fastidiosa mutants that lacked PG
expression. When inoculated in grapevines these mutants failed to cross pit membranes
and stayed in the vessel, in which they were inoculated, and failed to produce any PD
symptoms.
From the above examples it can be inferred that pathogenicity/virulence is an
interplay between attachment, biofilm formation and movement of bacteria within the
xylem vessels. Strong attachment to the xylem vessels restricts the movement of the cells,
which interferes with systemic infections. Mutants that attach strongly to the walls in
general are less virulent. On the other hand the mutants which are hypermotile and bind
loosely to the xylem walls are hypervirulent.
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Biology of H. vitripennis
H. vitripennis is the most important vector amongst the sharpshooter-vectors that
carry X. fastidiosa. Similar to other sharpshooters H. vitripennis transmits X. fastidiosa in
semi-persistent manner, though the exact mechanism of transmission is not known. H.
vitripennis acquires X. fastidiosa from the xylem vessels of an infected plant during
feeding. X. fastidiosa adheres and multiplies in the precibarium and cibarial region of the
insect foregut where it forms biofims. Both adult and nymphs are capable of acquiring
and transmitting X. fastidiosa. Once infected adult sharpshooters can harbor X. fastidiosa
in their foregut for their entire life, whereas the nymphs lose the bacteria along with the
cuticular lining of their foregut during molting. The nymphs have to reacquire the
bacteria to become infective again. Both adults and nymphs transmit X. fastidiosa to
naive plants without any latent period (Almeida and Purcell, 2003).
H. vitripennis has a transmission efficiency of ~20%. This is low compared to
other sharpshooters such as Graphocephala atropunctata, which transmits X. fastidiosa
with an efficiency of >90% (Almeida and Purcell, 2003; Hill and Purcell, 1995).
However, the GWSS makes up for this deficiency with high fecundity, long-range
mobility and ability to feed on hard wood (Redak et al., 2004). Feeding on hard wood
allows H. vitripennis to inoculate the bacterium away from the green portion of the plant,
which usually gets pruned during winter. These infections become chronic and persist in
the plants over winter. Sharpshooters such as G. atropunctata feed on the green part of
the plants only, which usually gets pruned during winter. This pruning helps the plant to
get rid of the infections. Thus sharpshooter feeding preferences play a major role in
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deciding whether the infections will persist into next summer or not (Almeida and
Purcell, 2003; Redak et al., 2004).
X. fastidiosa binds to and multiplies in the foregut of the insects. This is the only
niche other than plant xylem where bacteria survive. Binding to the foregut cuticle plays
an important role in survival and transmission of X. fastidiosa. Killiny and Almeida
(2009) demonstrated that X. fastidiosa binds to different carbohydrates with different
affinities. They tested different X. fastidiosa mutants and reported that mutants lacking
hemagglutnin-like proteins hxfA and hxfB expression lost their ability to bind to extracts
of G. atropunctata foregut. In their transmission experiment hxfA and hxfB mutants were
acquired at low rates in comparison to wild type X. fastidiosa, owing to their decreased
initial adhesion to insect foregut. The poor early colonization also diminished
transmission of hxfA and hxfB mutants compared to wild type X. fastidiosa.
Different molecules that interfere with X. fastidiosa binding to the sharpshooter
foregut can be used to block the disease transmission. Killiney et al. (2012) conducted
competition essays using different carbohydrates and X. fastidiosa surface protein
binding antibodies to block disease transmission by interfering with X. fastidiosa
attachment to the insect foregut. X. fastidiosa treated with GlcNAc, chitobiose (GlcNAc)2
and chitotriose (GlcNAc)3 and antibodies specific to afimbrial adhesins (XadA1 and
XadA2) and Hxfs (hemagglutunins) were transmitted at lower rates compared to controls.
This emphasized the importance of X. fastidiosa binding to the insect foregut in
transmission. This is in line with our hypothesis that we can block transmission by
targeting X. fastidiosa-GWSS interactions within the sharpshooter foregut utilizing a
genetically modified symbiont, which produces anti-Xylella molecules.

9

Disease Control
Different methods are used or under development to save the grapevines from the
menace of PD. A majority of grape growers rely on imidcloprid, a systemic insecticide,
to keep H. vitripennis populations low. However, recent reports show that different insect
species are developing resistance against imidacloprid (Zhao et al., 1995; Grafius and
Bishop, 1996; Prabhaker et al., 1997; vanToor et al., 2008; Gorman et al., 2008;
Matsumara et al., 2008; Wen et al., 2009), raising a red flag on over-reliance on a single
chemical. Additionally, researchers have tested an egg parasitoid, a mymarid wasp, for
its efficacy to control GWSS population in Southern California and it resulted in 30% egg
parasitism only (Pilkington et al., 2005).
Transgenic grape varieties, which either interfere with X. fastidiosa's ability to
cross xylem vessels by digesting pit membrane or produce antimicrobial peptides-scFv
chimeras, have also been developed. X. fastidiosa secretes an enzyme polyglactouronase
(PG) to digest pit membrane to further its spread within xylem vessels of a plant. Grape
vines expressing pear polygalactouronase-inhibiting protein (PGIP) were developed by
Aguero et al. (2005). These PGIP expressing grapevines interfered with the activity of
PG produced by X. fastidiosa and exhibited resistance to X. fastidiosa infections.
Dandekar et al. (2012) employed a different approach and developed transgenic grape
plants that expressed cecropin A-anti mopB-antibody chimeras. Cecropin A, an
antimicrobial peptide (AMP), was the active molecule against X. fastidiosa in that
chimera, whereas anti-mopB antibody provided specificity. These transgenic lines
harbored lower X. fastidiosa CFUs and were less symptomatic in comparison to the
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control line. These lines are still being tested under field conditions before they can be
released.
Insecticides, despite the concerns, are the main weapon against the vector. Until
now biocontrol has not offered reliable control of H. vitripennis. Transgenic grape lines
require uprooting and replacement of whole vineyards and this is not a cost effective

Figure 4. Paratransgenic control of Pierce's disease

measure. Therefore it is crucial to develop new strategies, which can be used to control
PD and other diseases caused by X. fastidiosa in other plant species. This dissertation
focuses on blocking transmission of X. fastidiosa by GWSS utilizing paratransgenesis
(Figure 4) with the following specific aims:
(i) Identification of P. agglomerans as a paratransgenic control agent for PD
(ii) Development of a viable and safe field release strategy
(iii) Achieving paratransgenic control of PD (Proof of concept)
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iv) Engineering of X. fastidiosa surface specific antibodies that can be used to
control PD by paratransgenesis of P. agglomerans
The paratransgenesis approach was first developed about two decades ago and has
not been applied in the field yet due to concerns over environmental contamination by the
released recombinant bacteria. The second chapter of this dissertation is focused on the
identification of P. agglomerans as a paratransgneic control agent for PD as well as
development of a method for field dispersal of genetically engineered P. agglomerans
lines. It describes binding and persistence of P. agglomerans inside the insect forgut, a
niche also colonized by X. fastidiosa. Further, the second chapter includes engineering of
calcium-alginate microparticles, which can be employed for field release of genetically
engineered P. agglomerans. We have submitted a manuscript describing the development
of Calcium alginate microparticles, which has been accepted and published in BMC
Biotechnology (Arora et al., 2015).
Chapter three is the heart of the dissertation and focuses on development of
paratransgenic H. vitripennis refractory to X. fastidiosa. After identification of P.
agglomerans as a paratransgenic control agent, the next step was to identify and express
anti-Xylella molecules via P. agglomerans and utilize those genetically modified P.
agglomerans lines to block disease transmission. The third chapter identifies two
antimicrobial peptides (AMPs), scorpine-like molecule (SLM) and melittin, as active
molecules against X. fastidiosa. The Escherichia coli hemolysin secretion system was
used to engineer P. agglomerans lines that can produce and secrete the active AMPs.
This chapter also includes generation of paratrangenic sharpshooters that were refractory
to X. fastidiosa acquisition and did not transmit the pathogen.
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We have used two AMPs as active molecules to block X. fastidiosa transmission.
However, AMPs are not specific and can kill a number of different microbes and
utilization of these molecules in the field may result in development of resistance.
Identification and engineering of other anti-Xylella molecules, which can be expressed in
tandem with these AMPs will reduce the risk of resistance development. Single chain
antibodies (scFv) are such molecules that are specific and can be used in tandem with
AMPs. The focus of the fourth chapter is engineering of scFvs that bind to mopB, a
surface protein of X. fastidiosa. A manuscript illustrating engineering anti-mopB
antibodies has been published in Applied and Environmental Microbiology (Azizi et al.,
2012). In future, we can engineer P. agglomerans lines that will express these scFvs
individually or in tandem with AMPs to block PD transmission.
Chapter five is the summary of all the chapters. It brings together all the aspects
of PD paratransgenic control and conclude the dissertation. It also talks about the future
application of PD paratransgenesis.
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Chapter 2: A Delivery System for Field Application of Paratransgenic Control

Abstract
Background
As an alternative to chemical pesticides, paratransgenesis relies on transformation
of symbiotic bacteria of an arthropod vector to deliver molecules that disrupt pathogen
transmission. For over a decade paratransgenesis has remained a laboratory-based
endeavor owing to regulatory concerns regarding introduction of transformed
microorganisms into the environment. To facilitate field application of paratransgenic
strategies, risk mitigation approaches that address environmental contamination and gene
spread must be developed.
Results
Using biopolymer manipulation, we introduce a novel microencapsulation
platform for containment and targeted delivery of engineered bacteria to the gut of a
disease-transmitting arthropod. We demonstrate the first proof of principle of targeted
delivery of EPA-approved Pantoea agglomerans E325 in a paratransgenic system to
control spread of Pierce’s Disease by glassy-winged sharpshooters, (GWSS,
Homalodisca vitripennis) under simulated field conditions. Engineered microcapsules
may address regulatory concerns regarding containment of recombinant bacteria and
environmental spread of foreign genetic material and may represent an important step in
translating paratransgenic science beyond the lab and into the field.
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Conclusions
We present, for the first time, a microencapsulation strategy to deliver
recombinant bacteria to an insect and demonstrate targeted release of bacteria into the
physiologically relevant region of the insect gut. This is a first step toward addressing
concerns related to field application of recombinant bacteria. Engineered microparticles
may decrease environmental contamination, horizontal gene transfer and competition
with native species by acting as a barrier between recombinant bacteria and the
environment.
Keywords
Paratransgenesis, Microencapsulation, Pierce's Disease, Xylella fastidiosa,
Homalodisca vitripennis, Pantoea agglomerans, Calcium-alginate.

Background
Arthropod-borne diseases remain a major threat to global health and exact a huge
toll on agriculture and food security. These diseases are largely controlled through use of
insecticides that reduce insect populations. Environmental applications of these chemicals
may be associated with toxic residues and emergence of target insect resistance.
Alternatives to insecticide-based control include paratransgenic manipulation of insects
with genetically engineered bacteria that deliver transmission-blocking molecules to
disrupt pathogens within the arthropod vector [1–7]. Though several paratransgenic
insect systems are under development, field use of this strategy has not yet been realized,
largely due to lack of delivery methods that target transformed bacteria to the arthropod
while minimizing collateral spread of foreign DNA. The United States Environmental
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Protection Agency (EPA) has issued guidelines for introduction of genetically engineered
(GE) species that state that GE organisms must: (a) Be contained to specific
environments of introduction, (b) Not out-compete native species for resources, (c)
Minimize foreign gene contamination (horizontal gene transfer) into native gene pools
[8].
Here we report a novel strategy for delivery of genetically-engineered bacteria in
a paratransgenic system that targets the glassy-winged sharpshooter (Homalodisca
vitripennis), a pest of grapes and citrus that spreads the pathogen, Xylella fastidiosa [9–
12]. Using simple and inexpensive materials for bioencapsulation [13–16] of the
engineered symbiotic bacterium, Pantoea agglomerans, we demonstrate targeting of the
sharpshooter, H. vitripennis, under controlled conditions with an alginate hydrogel that is
tuned to release its bacterial payload during xylem flow into the foregut of the insect. By
deploying a microencapsulation system that permits gated delivery of the bacterial
payload to the arthropod, while greatly minimizing release in the environment, we
believe that robust field-applicable technologies for paratransgenic control of arthropodborne diseases will be possible.

Results
A paratransgenic model for the glassy-winged sharpshooter (GWSS)
Pierce’s Disease (PD) of grapevines, caused by the bacterium Xylella fastidiosa,
is a devastating disease of grapes that threatens grape production worth $3.2 billion and
wine production worth $18.5 billion in California [17, 18]. Paratransgenic sharpshooters
can be an answer to the threat posed by PD. Early attempts to establish paratransgenic

22

sharpshooters were focused on the GWSS symbiont Alcaligenes xylosoxidans
denitrificans [10]. However, concerns that this bacterium may be a nosocomial human
pathogen led us to a grape endophyte bacterium, Pantoea agglomerans E325, currently
approved by EPA for control of fire blight in apples and pears [19]. We hypothesized
that the sharpshooter can acquire P. agglomerans in the same way as it acquires X.
fastidiosa. To test this we genetically engineered this bacterium to express enhanced
green fluorescent protein (EGFP) and ampicillin resistance and used an artificial feeding
system (AFS) to deliver recombinant bacteria to GWSS [20]. The GWSS was able to
acquire the engineered P. agglomerans from the artificial feeding system and EGFPexpressing P. agglomerans was found binding to the pre-cibarial and cibarial regions of
the insect foregut (Figure 1B). We further demonstrated that over a 15-day period,
which is one third of the insect’s lifespan, EGFP-expressing P. agglomerans persisted in
the insect foregut primarily colonizing the pre-cibarial and cibarial regions (Figure 2B).
We tested 522 sharpshooters over two seasons to study P. agglomerans persistence
inside the GWSS foregut and observed 42.2% foregut colonization with EGFPexpressing P. agglomerans over a period of 15 days. Carriage of P. agglomerans in the
foregut of sharpshooters was not affected by time (p=0.1979; chi-squared test). This
confirmed that, once acquired by the insect, P. agglomerans persisted in the foregut for
at least two weeks. Colonization with EGFP-expressing P. agglomerans occurs in the
same spatial niche as the pathogen X. fastidiosa (Figure1B) [21, 22], suggesting that P.
agglomerans may be used as a delivery vehicle for paratransgenic control of Pierce’s
Disease.
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Figure 1 Glassy-winged sharpshooters acquired EGFP-expressing P. agglomerans from an
artificial feeding system.
(A) Glassy-winged sharpshooters were allowed to feed on P. agglomerans through artificial feeding
system for 48 hours. These insect were then kept on naive plants for 24 hours to flush out the unbound
bacteria from the foregut before dissection. (B) Image showing EGFP expressing P. agglomerans
colonizing the foregut of GWSS. Inset: A higher magnification of same image showing P. agglomerans
colonizing cibarium and precibarium of the GWSS.
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Figure 2 EGFP-expressing P. agglomerans persisted inside the foregut of the glassy-winged
sharpshooter.
(A) GWSS were fed EGFP-expressing P. agglomerans via an artificial feeding system for 48 hours.
The insects were moved to naive grape plant for 24 hours to wash out unattached bacteria. They were
subsequently housed on another naive grape plant for up to 15 days. Insects were collected daily, and
processed as described. Homogenates were plated on LB plates to determine the presence of P.
agglomerans. (B) Percent of GWSS carrying EGFP-expressing P. agglomerans over a period of 15
days. No difference in proportions of GWSS carrying EGFP-expressing P. agglomerans was observed.
p=0.1979 by chi-squared test for homogeneity.
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Microencapsulation strategy for paratransgenic control
We developed a biopolymer microencapsulation system for paratransgenic
manipulation of sharpshooters with 4 overall goals: (1) encapsulation of transgenic
bacteria to keep them alive, contained and prevent horizontal gene transfer to
environmental bacteria (2) release of bacterial payload from capsules tuned to specific
physiologic conditions within the arthropod to minimize environmental contamination (3)
release of bacteria from the capsules to colonize the target region of the sharpshooter
where pathogens reside and (4) use of encapsulation materials that are inert in the insect
without adverse physiological impact.
A suitable polymer
We have developed a calcium-alginate microcapsule for containment of EGFPexpressing P. agglomerans (Figure 3). To ensure that the particles would fit in the
proboscis of the sharpshooter, we used a modified aerosolization-coascervation process
to generate micron-sized particles. The particle size varied from 6-90 µm, with 57% of
particles in the range of 22-44 µm (Additional File 3: Figure S3). By altering the particle
composition, we were able to achieve rapid and sustained release of bacterial payload in
response to sudden hydration. Calcium-alginate based microparticles (in absence or
presence of glycerol) resulted in sustained release of bacteria over a period of 7 days in
response to hydration, which was significantly higher than calcium/barium-alginate
microparticles (Additional File 4: Figure S4, p<0.0001). Maximum release of P.
agglomerans (CFUs = 1.03X105) was observed from calcium-alginate microparticles
with 10% glycerol over a period of 7 days, while minimum (CFUs=7.33) release was
observed from calcium/barium-alginate microparticles. Based on these results we decided
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Figure 3 Microparticles containing EGFP-expressing P. agglomerans.
(A) Calcium-alginate microparticles containing EGFP-expressing P. agglomerans(600X). (B) Same
field under fluorescence. (600X).

Figure 4 Bacterial survival under extreme dehydration.
Encapsulation of P. agglomerans significantly increases bacterial viability compared to unencapsulated
controls during desiccating conditions. Unencapsulated P. agglomerans died in a week after
dehydration, while encapsulated P. agglomerans survived for a month.
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to engineer calcium-alginate based microparticles for acquisition experiments to achieve
a quick as well as sustained release of bacteria inside the insect foregut after acquisition
of microparticles by the sharpshooters during xylem feeding.
The encapsulation process protected P. agglomerans from desiccating conditions,
which are expected during periods of coating on plants prior to ingestion by the
sharpshooter (Figure 4). Under extreme desiccation 100% of unencapsulated P.
agglomerans died within 7 days; on the other hand only 2 log decrease in colony forming
units (CFUs) was observed when encapsulated P. agglomerans were exposed to
desiccation for the same time period (Figure 4, p<0.001). We further observed that
calcium-alginate microparticles were able to keep P. agglomerans alive for 30 days,
though the number of CFUs in microparticles decreased over time. This survival of
bacteria during desiccation is important, as similar conditions are expected during
summer in grape growing areas of Southern California.
Addition of 0.5-1.0% of India ink to the particle confers high-level UV-resistance,
gain a desirable quality during periods of application on plants in the summer time
(Figure 5). Exposure of both encapsulated and unencapsulated P. agglomerans in the
absence of India ink to UVC resulted in 100% killing in 20 minutes. There was no
significant reduction in CFUs over a period of 60 minutes when P. agglomerans mixed
with alginate and India ink were exposed to UVC (Figure 5, p=0.051). However, when
Ca-alginate microparticles containing India ink were exposed to UVC there was one log
reduction in P. agglomerans CFUs in the first 5 minutes, (Figure 5) and CFU numbers
remained steady thereafter for next 55 minutes. We speculate that bacteria present on the
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Figure 5 P. agglomerans survival after exposure to UVC light.
Encapsulated and unencapsulated P. agglomerans in the absence of dye were killed after exposure to
UVC within 20 minutes, while both encapsulated and unencapsulated P. agglomerans in the presence
of dye were able to withstand UVC exposure for 60 minutes.

surface of microparticles were exposed to UVC and were killed in the first 5 minutes of
exposure, but the bacteria embedded in the microparticles remained protected.
We believe that calcium-alginate-10% glycerol hydrogel particles with India ink,
which protected against dehydration and UVC, are ideally suited to deliver transgenic P.
agglomerans under field conditions to the glassy-winged sharpshooter. We hypothesized
that these particles will swell during xylem flow and release the bacterial payload into the
foregut of feeding insects.
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A proof-of-concept
Glassy-winged sharpshooters were able to acquire P. agglomerans from alginatebased microparticles painted on grape plants. In a control group, GWSS fed on plants
painted with unencapsulated P. agglomerans, 85.7% of the insects acquired P.
agglomerans, which was significantly higher than the number of GWSS that acquired P.
agglomerans from plants painted with encapsulated P. agglomerans (Figure 6, p=0.016).
Amongst the groups of sharpshooters fed on encapsulated P. agglomerans maximum
colonization was observed in insects acquiring P. agglomerans from 1% alginate-based
microparticles (51.8%) followed by 2% (38.5%) and 3% (35.7%) alginate-based
microparticles. Though an increase in alginate concentration decreased P. agglomerans
acquisition by the GWSS, it was not statistically different between three tested
concentrations of alginate - 1%, 2% and 3% (Figure 6, p=0.476). Unencapsulated
treatments resulted in the maximum CFUs per insect head (mean CFUs = 245.4±80.4)
and minimum CFUs per head were observed in treatments using 3% alginate
microcapsules (mean CFUs = 52.1±22.7) (Figure 7). We did not observe significant
difference between Pantoea CFUs acquired by the insects from microparticles engineered
with 1%, 2% or 3% alginate (Figure 7, p=0.33).
Though the association between alginate concentration and Pantoea acquisition
did not attain statistical significance, there was a trend toward decreased Pantoea levels
in GWSS with increasing alginate in microparticles. This suggests that manipulation of
polymer composition may alter levels of bacterial colonization in the sharpshooter
foregut.

30

Figure 6 Glassy-winged sharpshooters acquired EGFP-expressing P. agglomerans from calcium
alginate microparticles.
Percent glassy-winged sharpshooters carrying EGFP-expressing P. agglomerans in their foregut. A
higher percent of GWSS acquired P. agglomerans from plants painted with unencapsulated P.
agglomerans than from plants painted with encapsulated P. agglomerans.* p<0.05 by chi-squared test
for homogeneity.** p>0.05 by chi-squared test for homogeneity.

Figure 7 Bacterial CFUs per insect head.
P. agglomerans (EGFP-expressing) colony forming units (log10) per insect head. No
difference in P. agglomerans CFUs acquired by the GWSS from plants painted with
unencapsulated or encapsulated P. agglomerans was observed. p> 0.05 by one-way ANOVA
with Tukey Simultaneous Tests for means with unequal variance.
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Discussion
Here, we report a new paratransgenic strategy for control of Xylella transmission
by the glassy-winged sharpshooter, H. vitripennis. P. agglomerans E325, an EPA
approved agent for biocontrol of certain crop diseases, has been genetically modified
using plasmid pT3078, which has the bla gene as a marker, to express recombinant EGFP
in the foregut of GWSS. We have demonstrated robust EGFP expression in the insect
foregut, in the region that harbors the plant pathogen, X. fastidiosa. Furthermore, we
report the use of a simple and inexpensive microencapsulation strategy to contain
engineered Pantoea and release the modified bacteria during conditions of xylem flux
into the anterior mouthparts of the feeding insect. Our results represent the first iteration
of this paratransgenic delivery system. Refinement of polymer chemistry and capsule
application may increase the percentage of GWSS that acquire transgenic Pantoea in
future trials. Chemical functionalization of the polymer backbone to enhance bacterial
release along with refined methods of increasing bacterial CFUs per capsule are currently
underway.
We propose the use of an EPA approved biocontrol agent, P. agglomerans E325,
as a paratransgenic control vehicle for PD. P. agglomerans colonized the foregut of the
insect from both an artificial feeding system and plants painted with unencapsulated and
encapsulated bacteria. P. agglomerans persisted in the insect foregut over the entire
duration of testing, up to15 days. The 15-day period is significant since it represents close
to one third of the insect's lifespan. Additionally, field applications of this approach could
involve bi-weekly delivery of encapsulated bacteria to grape plants, thus offering fresh
inocula to GWSS on a regular basis. P. agglomerans can be engineered to produce anti-
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Xylella molecules such as antimicrobial peptides (AMPs) or anti-Xylella antibodies to
block X. fastidiosa. We have used plasmid pT3078, which has the bla gene as a marker
in addition to an EGFP gene. However, for field application, Pantoea lines expressing
anti-Xylella molecules without antibiotic marker genes will be engineered. P.
agglomerans lines with fluorophore genes or REDantibody genes as markers are under
development for field release. These strategies, coupled with a refined delivery system,
will produce a robust toolset in the battle against GWSS-mediated PD transmission.
Field use of paratransgenic control for arthropod-borne diseases remains a future
prospect, largely due to concerns about the fate of engineered bacteria. In the current
model, we believe that environmental risks associated with release of foreign genes will
be reduced. First, plasmid decay for the recombinant P. agglomerans (Additional File 2:
Figure S2) occurs at the rate of 0.0533% per bacterial generation; thus engineered
bacteria are expected to revert to wild-type forms. Furthermore, engineered P.
agglomerans grows at a rate comparable to wild-type counterparts (Additional File
1:Figure S1), suggesting that it cannot out-compete the native organism. Second, we have
encased the recombinant symbiont in an alginate particle that inhibits release of payload
into the environment. Physical contact between engineered bacteria and native bacteria of
the rhizosphere or phytosphere is greatly impeded by the presence of capsules. Thus
horizontal gene transfer between engineered P. agglomerans and commonly present
bacteria of environmental consortia - a very rare event that occurs in the 10-8 to 10-9 range
(data not shown) - should be further diminished. The overall aim of this strategy is to
reduce horizontal gene transfer to levels that are acceptable to regulatory agencies, rather
than eliminating gene flow. Abolishing gene flow between environmental bacteria is an
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unrealistic goal. However, by providing a physical barrier via microparticles we can
minimize exchange between the large number of freshly released bacteria used in plant
inundation and environmental microbes, with the aim of reducing unwanted gene flow.
We have contained engineered P. agglomerans using calcium-alginate
microparticles. To deliver the bacteria to GWSS, we have chosen to paint growing grape
shoots, thus facilitating ingestion of the organisms during insect feeding. GWSS and
other sharpshooters are xylem feeders [21]. They initially contact a plant surface with the
tip of their stylet before penetrating into xylem vessels [22]. We hypothesize that
bacteria-laden microparticles that have been painted on plant shoots will contaminate the
lumen of the insect's stylet. During the sucking of xylem, hydrostatic pressure gradients
as high as 0.24MPa/cm [23], will cause rapid swelling of the alginate hydrogel and
release Pantoea into the cibarial region of the sharpshooter's foregut. To optimize release
of bacteria from the microcapsules and enhance colonization of the insect, hydrogels may
be tuned by varying the composition and concentration of divalent cations (Ca++, Ba++) as
well as alginate (Figures 6 and 7).
Over 80% of GWSS that were exposed to unencapsulated (naked) Pantoea during
feeding became colonized with the bacteria, at a mean CFU value of 245.4±80.4.
(Figures 6 and 7). We tested microparticles containing 1%, 2% and 3% alginate (w/v) in
the hydrogel. In all cases, there was a significant reduction in Pantoea acquisition when
compared to the control group (GWSS exposed to unencapsulated bacteria) (Figure 6).
When an alginate concentration of 1% (w/v) was used, target GWSS acquired Pantoea at
a rate of 51.8% with a mean CFU count of 186.6±68.9. This rate of acquisition was the
highest amongst the tested alginate concentrations and we believe that 1% alginate
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particles merit further attention. Rates of acquisition of encapsulated Pantoea by target
GWSS may have been lowered for several reasons. First, it is likely that the experimental
insects represented a heterogeneous population. It is difficult to maintain homogeneous
GWSS population under controlled conditions, thus, we used field-collected insects that
were previously colonized with environmental bacteria, genetically distinct and of
varying ages through the course of the summer. Second, we used a very limited time
frame for acquisition of bacteria through feeding by GWSS. It is likely that future field
applications that employ multiple treatments of plants with greatly protracted contact
time between GWSS and particles will increase colonization rates in the insect. Third,
many refinements in particle composition are possible. We are exploring use of particles
made of other materials that would dissolve in the presence of enzymes present in the
insect saliva to better release the bacterial payload. Attractants and feeding stimulants
may be incorporated to enhance bacterial delivery. Indeed, future versions of the
microencapsulation-delivery system should result in higher rates of target insect
colonization with engineered Pantoea.
Microencapsulation is a first step toward addressing concerns associated with
paratransgenic manipulation of arthropods. In this proof of principle, we deployed
microcapsules to deliver a recombinant bacterium to an insect. We designed the alginate
particles to swell under very high hydrostatic pressures encountered during xylem flux
and to decrease contact between engineered bacteria and the environment during periods
of application and residence on plants. Microencapsulation will decrease direct
interactions of released bacteria with other epiphytes when compared to unencapsulated
bacteria. This should also decrease the interactions of released bacteria with rhizosphere
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organisms. We believe this is a first step toward targeted delivery of recombinant bacteria
to arthropod vectors of disease. In ongoing projects, we are designing more advanced
particles that respond to specific physiological cues within insects, such as pH and blood
products, to establish a platform for field use of paratransgenics.
Based on this technology, microcapsule-based delivery of transgenic bacteria to
arthropods of clinical significance (sand flies, kissing bugs, mosquitoes) for human
vector-borne disease prevention becomes a real and logical extension, signifying a
paradigm shift in paratransgenic techniques from the lab to field settings. A
microparticle-based recombinant-bacterial release strategy could make paratransgenic
control of Chagas disease and malaria - for which paratrangenic manipulation has been
shown to decrease parasite load inside the vector - and other vector-borne diseases a
reality.

Conclusion
This is the first example of the use of microencapsulation to deliver recombinant
bacteria to an insect gut. We have demonstrated that transgenic symbiotic bacteria can be
delivered to the appropriate physiological niche within a disease-transmitting arthropod.
Furthermore, by acting as a barrier between transgenic bacteria and the outer
environment these microparticles should reduce competition between the recombinant
bacteria and native species, environmental contamination and horizontal gene transfer.
This platform may be expanded to deliver recombinant bacteria to other diseasetransmitting arthropod vectors, thus facilitating field use of paratransgenic control.
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Methods
Bacterial culture
P. agglomerans E325 culture was maintained on Luria Bertani (LB) agar at 30ºC
or in LB broth at 30ºC at 180 rpm.
Preparation P. agglomerans E325 competent cells
Bacterial cells were grown in 100 ml of LB medium at 30ºC with shaking at 175180 rpm. When OD600 was reached 0.4-0.6 the cells were harvested by centrifugation at
4000 rpm for 10 minutes at 4ºC. These cells were resuspended in 40 ml of ice cold Inoue
solution and harvested by centrifugation at 4000 rpm for 10 minutes at 4ºC. Bacterial
cells were then resuspended in 10 ml of Inoue transformation buffer. To this solution 0.7
ml of DMSO was added and the cells were stored in ice for 10 minutes. Aliquots of 70 µl
were made in microcentrifuge tubes and immediately snap frozen in liquid nitrogen. The
competent cells were then stored at -80ºC.
Transformation of P. agglomerans E325 with pT3078-5
Competent P. agglomerans cells were removed from -80ºC freezer, thawed and
kept on ice for 10 minutes. Two µl of plasmid pT3078-5 was added to the cells. pT30785 has an EGFP gene and bla gene (ampicillin resistant) as markers. The cells were
incubated on ice for 30 minutes followed by a heat shock at 42ºC for 90 seconds. The
tubes were then transferred to ice for 2 minutes. The cells were recovered by adding 800
μl LB medium and incubated at 30ºC with shaking at 180 rpm for 2 hours. These cells
were then transferred on to the LB agar supplemented with carbenicillin (100 mg/liter of
media) and incubated overnight at 30ºC. Next day single colonies were plated on LB agar
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with carbenicillin. Transformed P. agglomerans cells were tested for fluorescence and
confirmed by EGFP gene PCR.
Growth comparison
Wild-type P. agglomerans and EGFP-expressing P. agglomerans were grown
overnight in LB and LB+carbenicillin, respectively, to a stationary phase. They were then
diluted to 1/100 in 50 ml LB and were incubated at 30°C in a shaker incubator at 200
rpm. OD600 readings were taken hourly until cultures reached stationary phase.
In vitro plasmid stability
Transformed P. agglomerans were grown in LB supplemented with carbenicillin
for 10 hours at 28ºC with shaking at 175-180 rpm. These cells were diluted to ~1000
cells/ml and were grown for 10 hours (approx. 15 generation) in 25 ml LB broth without
antibiotic selection. After 10 hours of growth, log phase cells were added to 25 ml fresh
LB broth to a final concentration of ~1000 cells/ml and were grown again. This
procedure was repeated 5 times (total of 75 generation). Every 10 hours, while
transferring the cells to fresh medium, a fraction of cells was aliquoted and grown
overnight on LB agar without any selection. The next day 100 random colonies were
selected and streaked on LB agar supplemented with carbenicillin.
Acquisition of P. agglomerans to the GWSS using artificial feeding system
The EGFP plasmid containing P. agglomerans was grown overnight in LB broth
supplemented with carbenicillin. The next morning bacteria were centrifuged at 4000
rpm for 10 minutes followed by washing twice with the PBS. The bacterial cells were
resuspended in a solution of PBS (0.2X) and sugar (0.2%). This solution was filled into
plastic tubes with inner and outer diameter 1/8" and 3/16", respectively. These tubes were
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placed in 2.5" diameter vials individually. The vials containing the tubes were called the
artificial feeding system (AFS). The control AFS tubes were filled with the PBS-sugar
solution without bacteria. H. vitripennis, collected from the citrus orchard of Agriculture
Operations, UC, Riverside, were put into the control AFS and the bacteria containing
AFSs. These insects were given an acquisition access for 48 hours.
Maintenance of sharpshooters
After an acquisition access of 48 hours the insects were transferred to an insect
cage containing grape plants for 24 hours to flush out the unattached bacteria. After 24
hours of flushing, the insects were shifted to a new insect cage with clean grape plants.
The control (naïve) insects from the acquisition experiment were also transferred to the
clean plants. Everyday 5-15 insects were taken out from the cage for bacterial isolation.
Isolation of P. agglomerans from insect heads
Everyday 5-15 sharpshooters were taken out from bacteria and control groups and
surface sterilized in 70% ethanol and 10% bleach followed by washing twice with
autoclaved sterilized water. The heads of surface sterilized insects were cut with a sterile
surgical blade and were homogenized in 100 µl PBS using a homogenizer. This solution
was plated on carbenicillin supplemented LB agar plates.
General materials and method for alginate experiments
Protonal LF10-60 alginate (FMC Biopolymer, Sweden) was prepared at 1-3%
(w/v) concentration in de-ionized water and autoclaved prior to use. Bacterial cultures
were grown in LB broth overnight at 30ºC to plateau phase in 15 ml culture tubes,
pelleted at 4000 RPM at 4ºC for 15 minutes, washed twice with sterile 1X PBS, repelleted at 4000 RPM and supernatant decanted and re-suspended in 3 ml sterile 1X PBS
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before incorporating into the alginate. Bacterial-alginate suspensions were utilized
immediately after mixing. All experiments were performed in triplicate. Viable colony
forming units (CFUs) were evaluated using the pour plate method on selection agar.
Particle sizing was accomplished on a Microtrac s3500 laser diffraction analyzer
(Microtrac Systems).
Synthesis of calcium-alginate (Ca-ALG) or calcium/barium-alginate (CB-ALG)
microparticle
Alginate-bacterial suspension was produced as mentioned above. The resulting
mixture was atomized from an alcohol-sterilized airbrush into a vat containing sterile
0.05M CaCl2 with constant agitation from a distance of 20 cm. The resulting
microparticles were allowed to harden for 45 minutes and then harvested via vacuum
filtration through a sterile Nalgene filter-funnel with two pieces of sterile Nylon mesh
(pore sizes of 50 m and 35 m respectively) acting as filters. The microparticles were
harvested from the mesh and stored for future use.
In the case of CB-ALG microparticles, an equal volume of BaCl2 was added to
the CaCl2 solution after the 45 minutes gel time and the microparticles were allowed to
further gel for an additional 20 minutes. Microparticles were then collected as described.
Synthesis of carbon-calcium-alginate (CC-ALG) microparticles
For all experiments relating to carbon-calcium alginate particles, the alginatebacterial suspension was mixed with 1% vol/vol of sterile India Ink prior to particle
gellation. The rest of the protocol was left unaltered.
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Dehydration of Ca-ALG microparticles
Bacteria-containing Ca-ALG were produced as previously described. Ten gram
P. agglomerans Ca-ALG microparticles (1X107 CFUs/g) or 10 gm P. agglomerans in 5%
glycerol (v/v) slurry (1X107 CFUs/g) were then under sterile conditions transferred into
sterile 10 cm petri dishes and allowed to dry to constant weight under ambient conditions
and atmosphere (27ºC, 5-7% RH) overnight. Over the course of several weeks at various
time points 1 gm of dry slurry or dehydrated microparticles was transferred into fresh
sterile 0.15M sodium citrate and allowed to rehydrate/dissolve for 1 hour and then
serially diluted and plated on selection agar and incubated overnight. Viable CFUs were
assessed based on colony count.
Survival of encapsulated P. agglomerans E325 under highly sterilizing UVC
conditions
Bacteria-containing Ca-alginate microparticles both with and without India Ink
dye were produced as previously described. Ten grams of encapsulated P. agglomerans
E325 containing 2.0% (v/v) India Ink were placed in sterile open petri dishes 30 cm
directly under a columnated UVC germicidal lamp. Samples were exposed to sterilizing
radiation for 0-60 minutes, during which samples were chosen at random at various time
intervals and placed in fresh sterile microcentrifuge tubes containing 1ml sterile 0.15M
sodium citrate solution and left to dissolve over 1 hour. The liberated microbes were
serially diluted and plated on LB agar and left to incubate at 30ºC overnight. CFUs were
counted the following day.
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Diffusion from CA-ALG and CB-ALG microparticles
Bacteria-laden microparticles were produced as previously described. One gram
of microparticle slurry was mixed with 1ml of sterile water in a 1.5ml microcentrifuge
tube and allowed to stand at 4ºC for the prescribed time. At various time intervals
throughout the experiment, the tubes were vortexed vigorously for 10-15s to re-suspend
any diffused bacteria. The microparticles were allowed to settle for 5 minutes and then
50l aliquots were removed and serially diluted. Fifty l aliquots of each dilution were
then plated on selection agar and the plates were incubated overnight at 30ºC to
determine viable CFUs that had diffused from the microparticles.
P. agglomerans acquisition through microparticles
EGFP-expressing P. agglomerans-containing microparticles were engineered
using a 1%, 2% or 3% alginate as described above. Encapsulated bacteria were irradiated
three times with UVC for 90 seconds to kill any unencapsulated bacteria during the
production process. These microparticles were then mixed with 10% glycerol and 3%
guar gum and were applied to the grape plants. Field collected sharpshooters were
allowed to feed on these plants for 24 hours. As a control unencapsulated bacteria mixed
with 10% glycerol and 3% guar gum were applied to the grape plants. After 24 hours the
sharpshooters were removed from the plants and surface sterilized. The foregut and
midgut contents were homogenized as described above using a homogenizer. The foregut
and midgut contents were plated on LB+carbenicillin agar plates and were incubated at
30ºC. The CFUs were counted after 24 hours.
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Statistical analysis
Number of GWSS carrying P. agglomerans were compared using Chi-squared
test for homogeneity. P. agglomerans CFUs in various experiments with different
treatments were analyzed by Tukey's test for multiple comparison after taking log values
of CFUs. All the values are shown as mean±S.E. Statistical analysis were performed
using Minitab version 17 for windows 7. p values<0.05 were considered significant.

List of Abbreviations
GWSS - Glassy-winged sharpshooter
EGFP- Enhanced green fluorescent protein
AFS - Artificial feeding system
EPA - Environmental Protection Agency
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AMP - Antimicrobial peptides
LB - Luria Bertani
Ca-ALG - Calcium alginate
CB-ALG - Calcium/barium alginate
CC-ALG - Carbon calcium alginate
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Additional Files
Additional File 1: Figure S1
Comparison of growth of wild type P. agglomerans and EGFP-expressing P.
a
g
g
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o
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e
r
a
n
s
.
Figure S1 Comparison of growth of wild type P. agglomerans and EGFP-expressing P.
agglomerans.
Both the wild type and transformed P. agglomerans grew at a similar rate, which shows that the
plasmid pT3078 did not negatively affect growth of the transformed bacteria.
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Additional File 2: Figure S2
Loss of plasmid pT3078-5 by P. agglomerans over time.

Figure S2 Transformed P. agglomerans revert to its wild type form over time.
Percent P. agglomerans carrying EGFP-containing plasmid pT3078 in a culture kept at mid log phase
for 50 hours (~75 generation). P. agglomerans lost pT3078 plasmid at a rate of 0.0533 plasmids per
generation.
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Additional File 3: Figure S3
Size distribution of P. agglomerans containing microcapsules.

Figure S3 Size distribution of P. agglomerans-alginate microcapsules.
Size distribution of P. agglomerans-alginate microcapsules generated from a modified
aerosolization/coacervation process. (Inset) Electron micrograph of calcium-alginate encapsulated
EGFP P. agglomerans E325, size = roughly 10um (center) with 3-4µm microcapsules encapsulating
single bacteria.
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Additional File 4: Figure S4
Diffusion of microencapsulated P. agglomerans from Ca2+ and Ca2+/Ba2+ cross-linked
microparticles.

Figure S4 Diffusion of microencapsulated P. agglomerans from Ca2+ and Ca2+/Ba2+ cross-linked
microparticles.
Use of barium as a cross-linker greatly reduced the diffusion of bacteria from the microparticles.*, **,
*** and **** p < 0.001 by one-way ANOVA with Tukey Simultaneous Tests for means with unequal
variance compared to Ca-Alg and Ca-Alg+10% Glycerol microparticles on days 1, 3, 5 and 7,

respectively.
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Chapter 3: Paratransgenic Control of Pierce's Disease

Abstract
Arthropod vectors are the weakest link in the epidemiology and dissemination of
vector borne diseases. We can halt disease transmission either by killing the vectors or
targeting the pathogen or parasite within the vector's body. Paratransgenesis targets
pathogen within the insect gut by utilizing the symbiotic bacteria residing within the
same niche. We targeted Xylella fastidiosa, a bacterial pathogen that causes Pierce's
disease (PD) of grapevine, within the gut of its vector - the glassy-winged sharpshooter
(GWSS, Homalodisca vitripennis). We genetically modified Pantoea agglomerans E325,
utilizing the Escherichia coli hemolysin secretion system, to express and secrete two
antimicrobial peptides - melittin and scorpine-like molecule (SLM). Melittin and SLM
were selected for their expression via P. agglomerans after conducting in vitro studies
wherein both AMPs displayed higher toxicity towards X. fastidiosa in comparison to P.
agglomerans. These AMP-producing P. agglomerans lines were tested for their ability to
target X. fastidiosa within the sharpshooter foregut. Paratransgenic sharpshooters
carrying AMP-secreting P. agglomerans lines were refractory to X. fastidiosa and failed
to transmit X. fastidiosa to naive grape plants. For the first time, we demonstrated
utilization of paratransgenesis to make insect-vectors incompetent to acquire and transmit
a pathogen in an agricultural system. This PD paratransgenic strategy will act as model
system for other vector borne diseases.
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Results and Discussion
Despite advances in public health, arthropod vectors continue to exact a huge toll,
either directly through transmission of human pathogens or indirectly by causing diseases
in animals and agricultural crops. The global burden of plant diseases that are transmitted
by insects such as plant hoppers, aphids, whiteflies and thrips exceeds $10 billion, with
profound implications for food security. Toxicity of chemical pesticides, prohibitive costs
of sustaining pesticide campaigns and rapid evolution of insect resistance have
confounded efforts to control these scourges and underscore the need to develop alternate
approaches to pathogen control. Modulation of insects using transgenic symbiotic
bacteria- termed paratransgenesis- has been developed for several vectors of human
disease such as triatomine bugs, tsetse flies, sandflies and mosquitoes (Durvasula et al.,
1997; Aksoy et al., 2008; Hurwitz et al., 2011; Wang et al., 2012). This strategy relies on
delivery of anti-pathogen molecules within the arthropod vector via engineered symbiotic
bacteria to make the insect incompetent to carry and transmit the pathogen (Durvasula et
al., 1997). Several models of paratransgenic insects have been developed but to date none
has been validated as a method to block transmission of a pathogen and prevent disease
in a target host. Here, we report the paratransgenic manipulation of an agricultural pest,
Homalodisca vitripennis (Glassy Winged Sharpshooter), to block transmission of the
bacterial pathogen, Xylella fastidiosa, to grape plants. X. fastidiosa is currently a leading
agricultural menace globally, as the causative agent of Pierce's disease of grapevines,
citrus variegated chlorosis (CVC) of citrus crops and olive quick decline of olive trees
(Purcell, 2013; Saponari et al., 2015). Recent reports of decimation of European olive
trees (Stokstad, 2015) coupled with impacts on citrus and grape/ wine industries place the
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global burden of X. fastidiosa at several billion dollars. Leafhoppers commonly known as
sharpshooters are vectors of X. fastidiosa; amongst them, Homalodisca vitripennis
(glassy-winged sharpshooter, GWSS), due to its long-range mobility and high fecundity,
is the most important (Redak et al., 2004). We recently identified Pantoea agglomerans
as a symbiotic bacterium of H. vitripennis and, using an EPA-approved non-pathogenic
variant of Pantoea, reported both paratransgenic manipulation and a field-applicable
strategy to target GWSS with engineered bacteria (Arora et al., 2015). Using this
platform, we have engineered lines of P. agglomerans that secrete antimicrobial peptides
that kill X. fastidiosa and report here, for the first time, a pathogen-refractory agricultural
pest that is unable to infect target plants.
Antimicrobial peptides (AMPs) are defense molecules synthesized by higher
eukaryotes that kill pathogens in many ways, ranging from pore formation in the target
membrane to disruption of protein or nucleic acid synthesis or signal transduction
pathways (Brogden, 2005). Melittin, a 26 amino acid-long peptide having an alpha- helix
structure, is found in honeybee venom and kills cells through pore formation or by
inducing apoptosis (Oršolić, 2011). We selected melittin for delivery to the sharpshooter
gut via P. agglomerans. As a second effector molecule, we selected scorpine like
molecule (SLM). SLM is an AMP found in the venom of the scorpion Vaejovis
mexicanus. It is a 77 amino acid-long peptide having 44% homology with scorpine an
AMP from the scorpion Pandinus imperator. We analyzed its three dimensional structure
using I-TASSER (Yang et al., 2015; Roy et al., 2010), which predicted that it is
composed of three coil-helix structures (Fig. 1).
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a

b

Figure 1. The amino acid sequence and depiction of the three-dimensional structure scorpine-like
molecule (SLM) a) SLM sequence showing predicted domains with helix-coil structure. b) 3-D
structure of SLM as depicted by I-TASSER.

We tested activity of both peptides against X. fastidiosa as well as P.
agglomerans. Melittin killed X. fastidiosa at a concentration of 5µM, which was onefifth the concentration needed to kill P. agglomerans (25µM) (Fig. 2a and 2b). Similarly,
SLM killed X. fastidiosa at a concentration of 10µM, but had no effect on P.
agglomerans even at a concentration of 75 µM (Fig. 2c and 2d). This selective toxicity of
these molecules to X. fastidiosa rendered them ideal effectors for paratransgenic
manipulation of H. vitripennis.
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Figure 2. Toxicity of melittin and SLM against P.agglomerans and X. fastidiosa. 105-106 CFUs of
P. agglomerans and X. fastidiosa were treated with each AMP. O.D. 600 was measured 24 hours after
treatment of P. agglomerans with each AMP as it grows at a fast rate; while X. fastidiosa grows at a
slow rate and it was cultured 24 hours after treatment with each AMP and CFUs were counted. P.
agglomerans O.D.600 after treatment with a) melittin, c) SLM; X. fastidiosa CFUs counts after treating
with b) melittin, d) SLM.

To generate P. agglomerans strains that secrete melittin and SLM into the foregut
of H. vitripennis, we chose the Escherichia coli hemolysin secretion system, which has
earlier been used to secrete active molecules into the outside environment of gram
negative bacteria (Fernández et al., 2000; Wang et al., 2012). This secretion system is
composed of the pore forming proteins HlyB and HlyD and a carboxyl terminal HlyA
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a

b

Figure 3. Assembly and working mechanism of Escherichia coli hemolysin secretion system. HlyB
and HlyD formed pores in the internal membrane of Gram negative bacteria. These pores join pores
formed with TolC in the outer membrane and provide a passage to proteins with HlyA secretion signal
at their carboxyl end. a) Sketch depicting a protein with HlyA secretion signal passing through pore
formed by HlyB and HlyD in combination with TolC in the membrane of Gram negative bacteria. b)
Schematic description of introducing effector molecules at 5' end of E-tag in plasmid pEHLY A2-SD,
which was in frame with HlyA secretion signal.

secretion signal. Pores formed by HlyB and HlyD in combination with pores formed by
TolC provide proteins with an HlyA secretion signal passage to the outside environment
(Fig 3a). We introduced genes encoding melittin or SLM in the plasmid pEHLYA2-SD at
the 5'end of an E-tag, which was in-frame with the HlyA secretion signal (Fig 3b). We
transformed P. agglomerans with pVDL9.3, a plasmid with HlyB and HlyD genes, and
pEHLYA2-SD. These strains secreted melittin and SLM with the HlyA secretion signal
intact (Fig 4a, 5a).
We delivered P. agglomerans directly to the sharpshooters via guar gum that was
painted on grapevine stems at a concentration of 1010 CFUs/ stem as described byArora et
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Figure 4. Detection of excretion and accumulation of melittin and SLM conjugated to HlyA
secretion signal in the spent medium and within the sharpshooter gut by the transformed P.
agglomerans lines using an anti E-tag antibody. a) Spent medium of overnight P. agglomerans
cultures was concentrated using Micron 10kDa filters. This concentrated spent medium was tested using
anti-E-tag antibody via Western blot. Lane 1: ladder; lane 2: Wild type P. agglomerans; lane 3: HlyA
secretion signal only; lane 4: melittin conjugated to HlyA secretion signal; lane 5: SLM conjugated to
HlyA secretion signal. 4 (b) and ( c). Single surface sterilized sharpshooter was homogenized in PBS
using a homogenizer. Homogenized slurry was centrifuged @ 14000 rpm and supernatant was collected.
The collected supernatant was tested for presence of AMPs using an E-tag antibody. (b) Lane 1: ladder;
lane 2: sharpshooter fed on P. agglomerans expressing melittin conjugated to HlyA secretion signal; lane
3: sharpshooter fed on wild type P. agglomerans (c) Lane 1: ladder; lane 2: sharpshooter fed on P.
agglomerans expressing SLM; lane 3: sharpshooter fed on wild type P. agglomerans.
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Figure 5. Confirmation of excretion and accumulation of melittin conjugated to HlyA secretion
signal by transformed P. agglomerans lines in the spent media as well as within the sharpshooter
gut. (a) Spent medium was concentrated as described earlier and was analyzed using anti-melittin serum
via Western blot. lane 1: melittin conjugated to HlyA secretion signal; lane 2: synthetic melittin without
HlyA secretion signal; lane 3: ladder. (b) Solution from sharpshooter was prepared as described earlier.
This solution was analyzed using anti-melittin bleed. Lane 1: ladder; lane 2: sharpshooter fed on P.
agglomerans expressing melittin conjugated to HlyA secretion signal; lane 3: sharpshooter fed on wild
type P. agglomerans.

al. (2015). GWSS were allowed to feed on these plants for 48 hours. After P.
agglomerans acquisition, sharpshooters were infected with X. fastidiosa by feeding on
infected grape plants for 48 hours. These sharpshooters were collected and placed, two at
a time, on naïve grape plants for 24 hours to determine transmission of X. fastidiosa.
Sharpshooters that harbored AMP-producing P. agglomerans were refractory to X.
fastidiosa acquisition; insects that carried melittin- or SLM-secreting P. agglomerans, on
an average, had X. fastidiosa burden that was 4.28% and 0.22%, respectively, of the
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pathogen burden in control insects (p<0.00001) (Fig 6a). Furthermore, the number of
paratransgenic sharpshooters that carried X. fastidiosa in their foregut also decreased,
significantly: 80.55% of control sharpshooters acquired X. fastidiosa, while only 15.38%
of GWSS harboring melittin- and SLM-secreting P. agglomerans were found to carry X.
fastidiosa in their foregut (p<0.00001) (Fig 6b). Secretion of the HlyA signal peptide
alone by P. agglomerans in GWSS also decreased acquisition of X. fastidiosa; 43.75%
sharpshooters in this group acquired X. fastidiosa in their foregut. This is not surprisingly
as Wang et al. (2012) have also seen a decrease in Plasmodium acquisition by the
mosquitoes that carry HlyA secretion signal expressing bacteria.
Our next step was to determine whether decreased acquisition of X. fastidiosa by
H. vitripennis results in decreased pathogen transmission to naïve grape plants.
Sharpshooters that carry X. fastidiosa transmit the pathogen to grape plants
approximately 20 percent of the time (Almeida and Purcell, 2003). Paratransgenic
sharpshooters, that acquired melittin- and SLM- producing P. agglomerans strains prior
to acquisition of X. fastidiosa, failed to transmit X. fastidiosa to the naïve grape plants
(Fig. 7). Control sharpshooters and sharpshooters carrying wild type P. agglomerans
transmitted X. fastidiosa 16.67% and 20% of the time, respectively (Fig. 7).
Sharpshooters that carried P. agglomerans, which secreted only the HlyA signal protein
(and not the AMP molecules) also failed to transmit X. fastidiosa to the naïve plants. In
our laboratory model of Xylella transmission, we allowed 24 hours of inoculation access
and used 2 sharpshooters/plant. Under field condition more than 2 sharpshooters can feed
on the same plant for extended periods of time or even multiple times, which could result
in higher pathogen transmission than we observed in our experimental model.

60

We tested sharpshooters for the presence of recombinant AMP molecules to
confirm that decrease in Xylella transmission to grape plants was a result of AMP activity
in the insect gut. Grape plants were coated with 1010 CFUs of P. agglomerans per plant
via guar gum. GWSS were allowed to feed on these plants for 48 hours, then removed,
surface sterilized and tested for accumulation of peptides. Western blot analysis
established presence of both melittin and SLM within the insects (Fig Fig 4b, 4c).
Further, we confirmed presence of melittin using anti-melittin serum, which did not
cross-react with any of the sharpshooter proteins (5b).
Prior studies with paratransgenic arthropod vectors of disease demonstrated
reduction or elimination of pathogens in disease-transmitting insects (Durvasula et al.
1997, Wang et al. 2012). Here, we report a paratransgenic strategy that completely
eliminates transmission of a pathogen from an arthropod to a target plant. Three
molecules- the HlyA protein, melittin and SLM- when expressed in the sharpshooter via
engineered P. agglomerans, aborted transmission of X. fastidiosa to grape plants. Melittin
and SLM decreased Xylella CFU in paratransgenic sharpshooters to levels that should
eliminate pathogen transmission even during periods of feeding that exceed the 24 hour
window. Additionally, under field conditions, several sharpshooters may feed on a single
plant, unlike our experimental model in which only 2 insects were placed on target plants.
Again, the level of elimination of X. fastidiosa in the insect achieved with melittin and
SLM would stop transmission under such real world conditions. HlyA alone did reduce
X. fastidiosa acquisition by the sharpshooter and eliminated transmission in our study.

61

a

b

N

36

40

32

26

26

Figure 6: Graphs showing a decrease in X. fastidiosa acquisition by paratransgenic sharpshooters. P.
agglomerans was painted on the grape stems after mixing with guar gum. The sharpshooters were allowed to feed
on Pantoea painted plants for 48 hours before putting them in cage containing X. fastidiosa infected plant for 48
hours. Subsequently the sharpshooters were collected and two sharpshooters were caged on single naive grape plant
for 24 hours. These sharpshooters were surface sterilized and X. fastidiosa presence was tested using rt-PCR. Graph
depicting a) Prevalence of X. fastidiosa in the sharpshooter heads; a) X. fastidiosa CFUs per insect head.

62

However, the degree of X. fastidiosa reduction in the insect may not prevent transmission
under enhanced feeding settings.
Spread of Pierce’s disease and other vector-borne diseases is kept under check by
controlling vector populations with insecticides. There are reports of the development of
resistance in many insect vectors including mosquitoes and triatomine bugs against
various insecticides (Vassena, 2000; Picollo, 2005; Riaz, et al., 2013; Liu, 2015).
Paratransgenic control of these diseases is an alternative to insecticidal control, which can
be employed in the field to decrease transmission. It can also be included in integrated
vector management. We believe that paratransgenic control will reduce disease spread
and also will help to decrease over-reliance on chemical pesticides. We did not observe
adverse physiological effects in the sharpshooters carrying P. agglomerans strains, such
as decreased feeding or early mortality. Paratransgenic sharpshooters should be able to
complete their life cycle and there will not be any selection pressure on these insects,
which is the main cause of resistance development.
The sharpshooter foregut as compared to the grape plants carries far fewer X.
fastidiosa CFUs, which makes the insect gut an ideal place to attack X. fastidiosa. AMPs
expressed by P. agglomerans will encounter very few bacteria exerting less selection
pressure on the bacteria. Further, a low quantity of active molecules can combat the
pathogen within the gut. These are all factors that contribute to delay in resistance
development. Our lab has also developed single chain fragment variables (scFvs) specific
to X. fastidiosa surface protein, mopB (Azizi et al., 2012). These antibodies can be
expressed in tandem with active AMPs or as antibody:AMP chimeras to increase in the
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Figure 7 : Graphs showing a decrease in X. fastidiosa transmission by paratransgenic
sharpshooters.. P. agglomerans were painted on grape stems after mixing with guar gum. The
sharpshooters were allowed to acquire P. agglomerans from P. agglomerans painted plants for 48
hours before acquisition access of 48 hours on X. fastidiosa infected grape plants. Subsequently the
sharpshooters were collected and two sharpshooters were then confined on each naive grape plant.
After 24 hours of inoculation access the insects were removed and the plants were kept in greenhouse
for 30 weeks before testing them for presence of X. fastidiosa using rt-PCR. a) Percent plants infected
with X. fastidiosa in each treatment.

efficacy. The tandem expression of antibodies will further help to delay the development
of resistance.
The true potential of paratrangenesis in the field has not been realized yet largely
due to lack of application methods. We have already developed a strategy based on use of
calcium-alginate microparticles to disseminate the genetically modified bacteria in the
field. These microparticles not only provide a physical barrier between the bacteria and
the environment to decrease the environmental contamination, but also resulted in
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tolerance against desiccation and UV radiations (Arora et al., 2015). We can apply
microparticle containing recombinant P. agglomerans to fields in late spring for the
newly emerging sharpshooters to acquire AMP-expressing bacteria. This will make the
sharpshooter incompetent of transmitting the pathogen and thereby facilitating
transmission blockage.
The success of this PD paratransgenic model writes a new chapter in the control
of vector borne diseases in the field of agriculture. Whitefly, aphids, leafhoppers and
thrips transmit deadly diseases to crop plants ranging from cotton to papaya to rice. These
insects carry different symbionts that enhance their fitness and also provide them
resistance against biotic and abiotic stresses. We can use these symbionts as "Trojan
Horse" to block transmission of pathogens that are transmitted by these insects.
We are encouraged by the demonstration of complete transmission blockage by
the AMP-expressing P. agglomerans and we are confident that the transgenic bacteria
can be used individually or can be included as a component of integrated vector
management to save the grapevine from the menace of PD.

Materials and Methods
Sharpshooter maintenance
The glassy-winged sharpshooters (H. vitripennis) were collected from crepe
myrtle (Lagerstroemia sp.) trees planted in parking lot 9 of UC, Riverside. These
sharpshooters were kept on basil plants in cages until they were used.
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Bacterial strains, culture conditions and painting on to the plant
Escherichia coli strain XL1-Blue was used to maintain plasmids and for gene
cloning. Pantoea agglomerans E325, an EPA approved biological control agent, was
used to express and deliver different AMP molecules inside the sharpshooter gut. Both E.
coli and P. agglomerans were grown in Luria Barteni agar or broth. P. agglomerans and
E. coli were cultured on agar plates at 30°C and at 37°C, respectively. Broth cultures
were grown at the same temperatures in a shaker incubator (200 rpm). Carbenicillin or
chloramphenicol were added at a concentration of 100 µg/mL and 35 µg/mL,
respectively, when needed.
X. fastidiosa Temecula strain was used in toxicity assays and was cultured in PD3
agar at 28°C or in PD3 broth at 28°C. The shaker was agitated at 175-200 rpm to grow X.
fastidiosa in broth culture.
Toxicity of AMPs against P. agglomerans and X. fastidiosa
P. agglomerans was grown in LB broth overnight at 200 rpm in an shaker
incubator at 30°C. Next morning P. agglomerans was diluted 1/100 in 3 ml LB broth and
grown at 30°C to mid log phase. At mid log phase the bacteria were diluted (CFUs/mL)
in LB medium to 105-106 colony forming units/ml. Ninety µl of diluted P. agglomerans
was pipetted into sterilized 0.2 mL PCR tubes and to this 10 µL of 10X test concentration
of either melittin or SLM was added. These tubes were incubated overnight at 30°C and
next morning OD 600 was determined.
X. fastidiosa strain Temecula was grown in PD3 broth to its log phase. The
culture was then taken out and diluted to a concentration of 105-106 CFUs/mL in PD3
medium. 90 µL of diluted X. fastidiosa was mixed with 10 µL of 10X final concentration
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either AMP in a sterilized 0.2 mL PCR tube and was incubated overnight at 28°C in a
shaker incubator. X. fastidiosa is a slow growing bacterium, which makes measuring
change in OD 600 of overnight cultures unfeasible. Hence, after overnight treatment with
AMPs X. fastidiosa was plated on to PD3 agar. These plates were incubated at 28°C for
10 days and CFUs were counted.
Plasmid Construction
Melittin gene's sense and antisense sequences with NheI and XmaI overhang were
ordered from IDT(Coralville, Iowa, USA) and were annealed to themselves by lowering
the temperature by 1°C/min from 95°C to 50°C.

Fig 8. Cloning of melittin or SLM gene into pEHLYS2-SD

Scorpine like molecule (SLM), an AMP from Vaejovis mexicanus venom, gene
was amplified from a plasmid (kindly provided by Dr. Lorival D. Possani) using forward
primer (ScoHlyAF1.1) CAGCTAGCGGTTGGATAAGCGAG; and reverse Primer
(ScoHlyAR1.1) TTTTTTATAGGCACGGGGTATACC. The product was cut using
restriction enzymes NheI and SmaI.
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The plasmid pEHLYA2-SD (kindly provided by Dr. Luis A. Fernandez) - having
the hlyA secretion signal of the E. coli hemolysin secretion system- was also cut using
restriction enzymes NheI and SmaI. Melittin or SLM genes were ligated into linearized
pEHLYA2-SD plasmid. The in frame presence of both melittin and SLM genes was
confirmed by sequencing. The successful, inframe insertion of melittin or SLM gene
resulted in plasmid pEHLYA2-SD-Mel or pEHLYA2-SD-SLM.
P. agglomerans transformation
Overnight P. agglomerans was diluted in LB broth and grown to an OD600 of
0.6-0.7 (mid log phase). These cells were centrifuged at 4°C and 8000 rpm for 10
minutes and supernatant was removed. The
cells were washed with ice cold autoclaved
water. The final cell pellet of competent cells
was re-suspended in 1ml 10% glycerol.
Eighty µl of competent cell suspension was
aliquoted into microcentrifuge tubes. One µl
Fig. 9: Plasmid pVDL9.3

of pVDL9.3 plasmid (Fig. 9) was added to 80
µl of competent cells and transferred to an ice cold 1 mm cuvette. These cells were
electroporated at 2.0 kv, 25 microF. The cells were then plated onto chloramphenicolcontaining LB agar. Next morning the colonies were selected and presence of plasmid
was confirmed.
pVDL9.3 plasmid-containing P. agglomerans cells were made competent using
the above mentioned protocol and were transformed with plasmid pEHLYA2-SD or
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pEHLYA2-SD-Mel or pEHLYA2-SD-SLM. P. agglomerans containing both the
plasmids were selected on LB agar containing carbenicillin and chloramphenicol.
P. agglomerans Growth Curve
Wild type P. agglomerans and P. agglomerans secreting melittin, SLM or only
HlyA secretion signal were cultured overnight at 30°C in LB broth. Carbenicillin and
chloramphenicol were added to LB broth where needed. Next morning each culture was
diluted 1/50 in LB broth without antibiotic. The cultures were grown in a shaker
incubator at 30°C and 200 rpm and OD600 was measured every hour.
Detection of melittin and SLM in spent medium
Overnight cultures of P. agglomerans were centrifuged at 10000 rpm and the
supernatants were collected. The supernatant from each culture was concentrated using
10kDa NMWL filter (catalog #MRCPRT010, EMD Millpore, Temecula, CA, USA).
Twenty µL of concentrated spent medium was mixed with 5 µL of loading dye and run
on a 8-16% precast polyacrylamide gel (Catalog # 456-1103, Biorad, Hercules,
Califirnia, USA) at a constant electric potential of 150V. The proteins were then
transferred to a nitrocellulose membrane. The nitrocellulose membrane was first
incubated with primary rabbit anti-E-tag antibody, which was diluted to a dilution of
1:1000 in 10% milk-TBST, at room temperature. This membrane was washed 5 times
with TBST and incubated with mouse anti-rabbit antibody with AP conjugate, which was
diluted in milk-TBST to a dilution to 1:5000. This membrane was washed 5 times with
TBST and was developed using NBT and BCIP.
Presence of melittin in the supernatant was reconfirmed using rabbit anti-melittin
serum using the protocol as mentioned above. This serum was generated by immunizing
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rabbit with synthetic melittin and later collecting the serum. The serum was tested and
confirmed for its binding to melittin via ELISA.
X. fastidiosa transmission blocking assays
P. agglomerans lines were cultured in LB broth and overnight cultures were
washed twice with PBS. After washing, 1010 CFUs of P. agglomerans lines were
suspended in 3 ml PBS. Each suspension was mixed with 20 ml 3% guar gum (w/v).
One ml glycerol and 500 µl India Ink were added to it before this slurry was painted on to
grape stems. The plants were kept overnight to let the guar gum dry. These stems were
then covered with sleeve cages and field collected sharpshooters were released on these
plants. The sharpshooters were kept on these plants for 48 hours before putting them on
X. fastidiosa infected plants for another 48 hours. After acquisition access of 48 hours on
X. fastidiosa infected plants the sharpshooters were collected and two of each
sharpshooters were confined on naive grape plants for 24 hours. We used 2 sharpshooters
to inoculate X. fastidiosa on each naive grape plant to increase the percent transmission,
which is usually around 20 percent (Almeida and Purcell, 2003). The insects were
removed after 24 hours, surface sterilized and DNA was extracted before running realtime PCR. The inoculated grape plants were kept in the greenhouse for 30 weeks and
were tested for X. fastidiosa infection via real-time PCR.
DNA extraction from the insect head
The sharpshooters were surface sterilized by washing them in 70% ethanol for 2
minutes followed by washing in 10% bleach for 2 minutes. Subsequently these
sharpshooters were washed twice in sterilized water for 2 minutes. The heads were
removed from the sterilized sharpshooters' bodies using surgical blade. The
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sharpshooters' heads were then homogenized in 200µL PBS using a Kontes homogenizer
and DNA was extracted using DNeasy Blood and Tissue Kit (Catalog # 69504, Qiagen,
Valencia, CA, USA) following manufacturer's instructions.
DNA extraction from plant tissues
After 30 weeks of inoculation stems of ~ 8 cm were cut from plants. These stems
were sterilized by washing in 70% ethanol and 10% bleach for 2 minutes each, followed
by 2X washing in sterilized water for 2 minutes. These stems were put in Adagia bags
(Catalog # ACC 00930/0100, Elkhart, IN, USA) and homogenized in 800 µL of lytic
buffer (20 mM Tris-Cl pH 8.0, 70 mM Sodium EDTA, 2 mM Sodium Chloride, 20 mM
Sodium Metabisulfite) using mortar and pestle. 200 µl of plant tissue suspension in lysis
buffer was placed in a 1.5 ml microcentrifuge tube. This suspension was incubated at
55°C for 1 hour after adding 40µl of 5% sodium sarkosyl and 1.5 µl of proteinase K.
After 1 hour of incubation this suspension was centrifuged at 13,000 rpm for 15 minutes
and supernatant was collected. DNA was purified from the supernatant using a
GeneClean kit (Catalog #111001200, MP Biomedicals, Santa Ana, CA, USA) following
manufacturer's instructions.
Real-time PCR
We used ITS-specific primers and probes described in Schaad et al. (2002) to run
real time-PCR. The 20µl reaction was performed in 0.1ml strip tubes containing 10 µl 2X
IQ Supermix (Biorad), 100nM forward primer, 200 nM reverse primer, 200 nM Taqman
probe with dye, 5.8 µl of PCR-grade water and 2 µl of template DNA. The real-time PCR
was performed on the Eppendorf Realplex at 95ºC for 3 minutes for enzyme activation
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followed by denaturation at 95ºC for 15 seconds, and extension and annealing at 62ºC for
1 minute. The PCR was run for 40 cycles.
Detecting accumulation of AMPs inside the insect body
The glassy-winged sharpshooters were surface sterilized as mentioned above. The
whole sharpshooters were then homogenized in PBS using a Kontes homogenizer. The
homogenized solution was then centrifuged at 13,000 rpm for 10 minutes and supernatant
was used for AMP detection. Twently µl of supernatant was mixed with 5µl of reducing
marker and was run on precast Mini PROTEAN TGX gels. Proteins were transferred on
to nitrocellulose membranes as mentioned above and accumulation of protein was
detected using primary rabbit anti-E-tag antibody as mentioned above.
Accumulation of melittin inside the insect body was confirmed using rabbit antimelittin serum. The protocol for Western blot was used as mentioned above.
Statistical analysis
Chi-square test for homogeneity was employed to compare number of GWSS
carrying X. fastidiosa in their foregut. X. fastidiosa CFUs present in GWSS foregut in
various treatments were analyzed by Tukey's test for multiple comparison after taking log
values of CFUs. All values are shown as mean±S.E. Statistical analysis were performed
using Minitab version 17 for windows8. p values<0.05 were considered significant.
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Chapter 4: Ribosome Display of Combinatorial Antibody Libraries Derived from
Mice Immunized with Heat-Killed Xylella fastidiosa and the Selection of MopBSpecific Single-Chain Antibodies

Abstract
Pierce's disease is a devastating lethal disease of Vitus vinifera grapevines caused
by the bacterium Xylella fastidiosa. There is no cure for Pierce's disease, and control is
achieved predominantly by suppressing transmission by the glassy-winged sharpshooter
insect vector. We present a simple robust approach for the generation of panels of
recombinant single-chain antibodies against the surface-exposed elements of X.
fastidiosa that may have potential use in diagnosis and/or disease transmission blocking
studies. In vitro combinatorial antibody ribosome display libraries were assembled from
immunoglobulin transcripts rescued from the spleens of mice immunized with heatkilled X. fastidiosa. The libraries were used in a single round of selection against an outer
membrane protein, MopB, resulting in the isolation of a panel of recombinant antibodies.
The potential use of selected anti-MopB antibodies was demonstrated by the successful
application of the 4XfMopB3 antibody in an enzyme-linked immunosorbent assay
(ELISA), a Western blot assay, and an immunofluorescence assay (IFA). These
immortalized in vitro recombinant single-chain antibody libraries generated against heatkilled X. fastidiosa are a resource for the Pierce's disease research community that may be
readily accessed for the isolation of antibodies against a plethora of X. fastidiosa surfaceexposed antigenic molecules.
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Introduction
Xylella fastidiosa includes a group of closely related pathogens, each affecting a
specific plant target. One subspecies affects grapevines, but little else, another subspecies
affects almonds and grapevines, and still another affects only oleanders (1). The
subspecies Xylella fastidiosa subsp. fastidiosa (Xanthomonadales: Xanthomonadaceae) is
a pathogen of the grapevine (14), an economically important crop in California. This
bacterium is the causative agent of Pierce's disease (PD) of grapevines and is vectored by
the leaf hopper Homalodisca vitripennis (Germar) (Hemiptera: Cicadellidae)
(formerly H. coagulata), also known as the glassy-winged sharpshooter (GWSS) (39).
The precise pathogenic mechanisms resulting in disease are not clearly understood;
however, the ability of the pathogen to colonize in both the xylem of the grapevine and in
the foregut of the GWSS vector is well established (11). The X. fastidiosa genome has
been sequenced, and comparative analysis has provided valuable information of genes,
metabolic pathways, and potential virulence factors that may be involved in pathogenicity
(43).
Investigating the interfaces between the plant-pathogen-insect interactions may
reveal sites for molecular interventions that could confer resistance or reduce
transmission of the pathogen. It is possible to predict and explore the surface-exposed
components that may play a role in bacterial virulence and/or be involved in attachment
or biofilm formation in either the plant or arthropod. The function of surface-displayed
targets may also be probed using lectins or polyclonal antibodies (29). However, if
monoclonal antibody (MAb) tools were available, they would allow a more detailed
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study of the assembly, distribution, function, and the role of such targets in plant-vector
interactions.
The desire for the efficient rapid generation of MAbs to biologically important
protein antigens over the past 2 decades has driven the development of a range of in
vitro technologies based on combinatorial immunoglobulin repertoire cloning (26), highthroughput screening, phage display (4, 27, 37), and ribosome display (22, 23, 36). For
ribosome display, immunoglobulin mRNA transcripts can be isolated from antibodyproducing cells, converted to cDNA, and assembled in vitro to create linear DNA
templates encoding libraries of single-chain-fragment variable antibodies (scFv's), which
can be transcribed in vitro into mRNAs that lack a termination codon. Translation of
mRNA templates in the absence of a stop codon results in each ribosome stalling at the
last codon and retaining the correctly folded antibody polypeptide and the mRNA,
creating tripartite antibody-ribosome-mRNA complexes (ARMs) (see Fig. 2). The library
of ARMs can then be affinity enriched to select the desired ARM for recovery. The
essence of the approach is the linking of the recognition function to the replication
function, i.e., linking the phenotype to the genotype (27). Recombinant protein display
technologies allow ready access to genetically encoded ligands or receptors for defined
targets, an approach pioneered more than 25 years ago (44).
The aim of this study was to create an antibody resource from mice immunized
with X. fastidiosa that would permit the isolation of recombinant antibodies against
surface-accessible molecules on X. fastidiosa and to validate the approach by selecting
scFv's against the outer membrane protein MopB (8).

79

Materials and Methods
Bacterial strains and plasmids
The oligonucleotide primers used in this study are listed in Table S1 in the
supplemental material. The pSANG10-3F vector (42) was provided by John McCafferty
(University of Cambridge) and used with the XL1-Blue Escherichia coli strain
(Stratagene) for plasmid construction and the BL21(DE3) or Rosetta gamiB (DE3) E.
coli strain (Novagen, United Kingdom) for recombinant protein expression. David Lampe
provided the pMALc2x_mopB plasmid. Plasmid pAHAHis for scFv bacterial
cytoplasmic expression was based on modified pET32a (unpublished data). The plasmid
pFab1-PhoA-H (47) was provided by Masataka Takekoshi (Tokai University, Japan). The
anti-NANP repeat monoclonal antibody 2A10 (38, 49) VH and VL sequences were
provided by Anthony A. James (University of California Irvine). The Xylella
fastidiosa Temecula1 strain was prepared at the University of California Riverside in the
laboratory of Thomas A. Miller.
MopB
The complete amino acid sequence of the X. fastidiosa Temecula1 strain (NCBI
NP_779898.1) MopB was submitted to web-based protein prediction programs, namely,
SIG-Pred (signal peptiderediction;http://bmbpcu36.leeds.ac.uk/prot_analysis/Signal.html ) (6) and the
PRED TMBB website, which hosts a Hidden Markov Model method, capable of
predicting transmembrane beta-strands of outer membrane proteins of Gram-negative
bacteria (http://biophysics.biol.uoa.gr/PRED-TMBB/) (2, 3, 45), to identify the signal
peptide and the putative surface-exposed domains, respectively. The predicted encoded
mature domain (MopB = 354 amino acids [aa]) and surface-exposed domain (MopB =
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182 aa) were PCR amplified using primers designed to include the NdeI (5′) site
encoding an in-frame methionine start codon and the NotI (3′) site encoding an in-frame
triple alanine (primers are listed in Table S1 in the supplemental material). The MopBencoding inserts were PCR amplified using a pMALc2x_mopB template. The PCR
products were restricted with NdeI and NotI and inserted into pSANG 10-3F vector to
produce proteins with in-frame C-terminal sequence
[AAASA(H)6KLDYKDHDGAYKDHDIAYK(D)4K]. The molecular masses and
isoelectric points were predicted using the ExPASy bioinformatics resource portal
(http://web.expasy.org/compute_pi/) (20). The plasmids were used to transform XL1Blue E. coli cells and confirmed by DNA sequencing.
Bacterial expression of recombinant MopB
Plasmids encoding recombinant MopB were transformed into BL21(DE3) E.
coli cells (Novagen) and grown in 200 ml of LB medium containing kanamycin (30
μg/ml) at 37°C with shaking at 250 rpm until an optical density (OD) at 600 nm of 0.4 to
0.6 was reached. Protein expression was induced by the addition of isopropyl β-D-1thiogalactopyranoside (IPTG; final concentration, 0.3 mM), and incubation was resumed
for 3 h before harvesting was performed by centrifugation at 5,000 rpm and 4°C for 20
min (using a Sorvall Super T 21 benchtop centrifuge, with an SL-250T rotor). Cell pellets
were frozen and stored at −80°C.
Recombinant MopB extraction
The cell pellet obtained from 200 ml of culture was resuspended in 5 ml of
denaturing lysis buffer (6 M guanidine hydrochloride, 10 mM Tris-HCl, 500 mM NaCl,
10 mM imidazole, pH 8.0). The cells were lysed by sonication on ice (6 30-s pulses) in an
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ultrasonic cell disruptor and centrifuged at 16,000 rpm for 45 min to pellet the cellular
debris. The supernatant containing soluble material was retained for the subsequent
purification using Ni2+-nitrilotriacetic acid (Ni2+-NTA) agarose affinity resin. A 1-ml
volume of nickel-chelating agarose slurry (G-Biosciences) was applied to a 10-ml
column and equilibrated with 5 ml of wash buffer (8 M urea, 10 mM Tris-HCl, 100 mM
NaH2PO4, pH 8.0). The supernatant containing the hexahistidine-tagged protein was
loaded onto the resin. The flowthrough was collected and the resin washed with 5 ml of
wash buffer (8 M urea, 10 mM Tris-HCl, 100 mM NaH2PO4, pH 6.3). The bound
recombinant MopB fusion proteins were eluted in 1 ml of elution buffer five times (8 M
urea, 10 mM Tris-HCl, 100 mM NaH2PO4, pH 4.5). Fractions were analyzed by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (27) using 12% Trisglycine gels and visualized using a fast microwave-assisted Coomassie stain technique
described elsewhere (34). Protein concentrations were estimated using the Bradford dye
binding assay (6).
Mouse immunization
The X. fastidiosa Temecula 1 strain was grown in PD3 media (13) (100 ml) in a
0.5-liter flask at 28°C at 180 rpm for 10 days until an OD at 600 nm of 0.5 was reached.
The bacteria were pelleted and resuspended in 100 ml of PBS twice, the final pellet wet
weight was determined, the pellet was resuspended in PBS at 10 mg/ml (wt/vol) and 1-ml
aliquots were prepared. An aliquot of the X. fastidiosa bacteria was incubated at 28°C
(viability; positive control) and the remainder heat treated at 55°C for 1 h and checked for
viability by plating on PD3 agar and incubation for 15 days at 28°C; the remainder of the
bacterial vials were frozen at −80°C. Once it had been confirmed that no viable bacteria
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were present in the heat-treated ampules, aliquots were sent to ProSci Inc. (Poway, CA)
for immunization of BALB/c mice (n = 5). The initial immunization (0.5 ml/mouse) was
followed by boosting at weeks 4 and 8 and 12. Test bleeds were taken a week after the
third boosting for enzyme-linked immunosorbent assay (ELISA) and dot blot analysis.
Following testing, mice were boosted and 3 days later underwent a splenectomy; each
spleen was placed in 10 ml of TRIzol (Invitrogen, Carlsbad, CA) for use in RNA
isolation.
MopB ELISA
Recombinant MopB (10 μg/ml) or bovine serum albumin (BSA) (10 μg/ml) in
phosphate-buffered saline (PBS) (pH 7.4; 0.1 ml/well) were used to coat a 96-well plate
(Nunc) at 4°C overnight and blocked with 0.2 ml of 2% BSA–PBS at room temperature
for 1 h. Polyclonal sera from mice (n = 5) previously immunized with whole heatkilled X. fastidiosa were diluted to 1/20,000 in PBS containing 0.05% Tween 20 (PBST), added in duplicate to the wells (0.1 ml/well), and incubated at 37°C for 2 h. The wells
were washed with PBS-T, and 0.1 ml/well of rabbit anti-mouse antibody (Sigma-Aldrich)
diluted 1:20,000 in 1% BSA–PBS-T was added and incubated at 37°C for 2 h. The plates
were washed as before, and 0.1 ml/well of goat-anti-rabbit IgG alkaline phosphatase
conjugate (Sigma-Aldrich) (diluted 1:40,000 in 1% BSA–PBS-T) was added and
incubated at 37°C for 2 h. The plates were washed as before with an additional final wash
with PBS alone and developed with p-nitrophenyl phosphate (1 mg/ml)–0.2 M Tris
buffer (pH 8.0) (0.1 ml/well) at 37°C for 30 min. The absorbance was measured at 405
nm on an ELISA plate reader (VersaMax; Molecular Devices, United Kingdom).
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Bacterial dot blot assay
Strips of nitrocellulose ∼5 mm wide were spotted with 5 μl of 5% (wt/vol)
skimmed milk powder–PBS, 5 μl of a bacterial suspension of E. coli, and 5 μl of the X.
fastidiosa Temecula1 strain, allowed to air dry, blocked with 1% BSA–PBS, and
incubated with immune sera (bleed 3) diluted 1/20,000 in PBS-T with 1% BSA for 1 h.
Following washing with PBS-T, the mixture was incubated with rabbit anti-mouse
alkaline phosphatase antibody (Sigma-Aldrich), diluted 1:20,000 in 1% BSA–PBS-T for
1 h, washed as before, and developed with a mixture containing 0.02% 5-bromo-4chloro-3-indolylphosphate (BCIP), 0.03% nitroblue tetrazolium (NBT), 10 ml of 100 mM
Tris, 100 mM NaCl, 5 mM MgCl2, and 0.05% Tween 20 (pH 9.5).
Mouse immunoglobulin library assembly
The mouse spleens, each in 10 ml of TRIzol (Invitrogen), were shipped on dry
ice and stored at −20°C prior to processing. Upon thawing at room temperature, each
sample was macerated using an IKA T8 Ultra-Turrax homogenizer and processed
following the instructions for total RNA isolation (TRIzol; Invitrogen). The resulting
RNA pellets were dissolved in 50 μl of RNase-free water and analyzed using a NanoDrop
apparatus (Thermo-Fisher, United Kingdom) to determine relative purity and RNA
concentrations and stored at −20°C until required. First-strand cDNA was synthesized
from ∼1 μg of total RNA by the use of a ProtoScript First Strand cDNA synthesis kit (MMuLV) and reverse transcriptase (RT; New England BioLabs) with Oligo-dT29VN for
light chains and MVHLink2 for the heavy chains, following the instructions provided.
For antibody library construction, the PCR primers were based on published sequences
(26, 28) with minor modifications (see Table S1 in the supplemental material). The
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FIG 1 An illustration of the mouse immunoglobulin DNA library assembly process, showing the PCR
amplification and assembly steps. The corresponding representative agarose gels resolved PCR products
for each of the steps generated using mouse 4 spleen total RNA.

primers were designed to introduce in-frame NcoI and NotI restriction sites to the 5′ end
of the VL sequence and to the 3′ end of the VH sequence, respectively, as shown in Fig. 1.
Members of the light-chain families were individually amplified by PCR using the OligodT29VN cDNA template and combinations of MVKF1–7 with MVKR. Members of the
heavy-chain families were individually amplified by PCR using MVHLink2 cDNA
templates and combinations of MVHF1–10 and MVHR1.1. The amplified light-chain
products were purified and pooled, and an aliquot was subjected to another round of PCR
amplification using MVKFLink and MVKRLink to introduce part of the T7 site and
Kozak sequence (32) on the 5′ end and an overlap extension on the 3′ end to facilitate
joining to the variable heavy-chain libraries. The amplified heavy-chain products were
processed and modified in a similar manner using primers MVHFLink and MVHR1.1.
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The modified variable light- and heavy-chain products were combined and amplified
using MVKFLink and MVHR1.1. A synthetic mouse kappa constant (MKC) domain
(optimized for E. coli codon usage and synthesized by Epoch Biolabs, Sugar Land, TX)
was amplified using MKNotCF and MKRev. The MKC was joined to the VL-linkVH combinations by a PCR overlap extension reaction using MVKFLink and MKRev
(Fig. 1). Finally, the PCR product encoding all the variable light-chain and heavy-chain
combinations was amplified with primers RDT7 and MKRev to produce the DNA
encoding the anti-X. fastidiosa immunoglobulin scFv libraries. The initial PCR
amplification reactions were performed at a 50°C annealing temperature with 30 cycles,
and the subsequent library assembly step used 16 cycles with Taq DNA polymerase and
20 pmol of each primer pair per reaction. DNA fragments were resolved by gel
electrophoresis on 2% (wt/vol) agarose gels. DNA isolation from agarose gels was
carried out following Qiagen DNA gel purification kit instructions. In total, five
combinatorial scFv antibody DNA libraries were constructed.
Antibody ribosome display
To select for single-chain antibodies, a modified eukaryotic ribosome display
(23) was used as outlined in Fig. 2. The PCR-generated DNA library of antibody-coding
genes derived from mouse 4 were expressed in a coupled rabbit reticulocyte lysate
system (Promega; TNT quick-coupled transcription-translation system). An in vitrocoupled transcription-translation reaction was set up in a 0.5-ml tube as follows: to 40 μl
of TNT T7 Quick Master Mix, 2 μl of DNA library (0.1 to 1.0 μg), 1 μl (1 mM) of
methionine, 1 μl of DNA enhancer, and 6 μl of water were added, and the reaction
mixture was incubated at 30°C for 90 min. Then, 6 μl of RNase-free DNase I (Roche)
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FIG 2 A schematic of the steps involved in in vitro antibody ribosome display. Step 1: the scFv
antibody library DNA template was prepared flanked with a T7 sequence and mouse kappa constant
sequence. Step 2: the antibody library DNA was transcribed to mRNA and translated to form an
antibody-ribosome-mRNA complex. Step 3: the mixture was incubated with immobilized truncated
MopB. Step 4: the unbound components were removed by washing. Step 5: the retained complexes
were released. Step 6: the mRNA was reverse transcribed and amplified by PCR. Step 7: the PCR
products were cloned into TOPO vectors and recovered plasmids sequenced. Full-length in-frame scFv
sequences were inserted into pAHAHis vector for recombinant antibody production.

(10,000 U/ml) was added, and the mixture was incubated for 20 min at 30°C (to degrade
input DNA). To select specific antibody fragments, a 0.5-ml PCR tube was coated with
0.1 ml of recombinant truncated MopB (10 μg/ml)–PBS at room temperature for 1 h,
washed with PBS, and blocked with 100 μl of molecular-biology-grade BSA–PBS (10
mg/ml) (New England BioLabs) for 1 h. The translation-transcription mixture containing
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the antibody-ribosome-mRNA complexes was added to a MopB-coated tube and
incubated on ice for 1 h. The tube was washed by filling once with PBS (0.5 ml) and
decanting and carefully removing the residual liquid by the use of a sterile pipette tip.
The retained RNA was recovered using an RNeasy (350 μl) Mini protocol following the
manufacturer's instructions and used in OneStep (Qiagen) RT-PCR with MVKFLink and
MKRD2 primers to amplify the antibody encoding DNA in a 50-μl reaction mixture by
the use of 6 μl of RNA template and 5 μl of each primer (20 pM). The mixture was
cycled at 50°C for 30 min and 95°C for 15 min and then 35 cycles of 94°C for 30 s, 52°C
for 30 s, 72°C for 1 min, and 72°C for 5 min and finally kept at 8°C. The RT-PCR
product from a single round of ribosome display was purified by agarose gel
electrophoresis and cloned into pCRII-TOPO vector (TOPO TA cloning kits; Invitrogen)
according to the manufacturer's instructions and used to transform XL1-Blue competent
cells. Plates containing 5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-Gal)
were used to select for disruption of the β-galactosidase. Four white colonies were
randomly selected and inoculated into 10 ml of LB media with carbenicillin (100 μg/ml);
plasmid DNA was isolated from E. coli by the use of standard procedures and a QIAprep
Spin Miniprep kit (Qiagen) following the manufacturer's instructions, and DNA was
sequenced at the core facility at The Wolfson Institute for Biomedical Research,
University College London.
ScFv expression
An scFv antibody cytoplasmic expression vector with a carboxyl-terminal-tag
peptide sequence derived from influenza virus hemagglutinin (HA) (Asp Val Pro Asp Tyr
Ala Ser [DVPDYAS]) followed by a hexahistidine tag designated pAHAHis was
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constructed based on pET32a. The recovered single-chain antibody-encoding sequences
were inserted into pAHAHis plasmid as NcoI-NotI fragments for cytoplasmic expression
in Rosetta gami B (DE3) E. coli. The pAHAHis encoding the scFv was transformed into
Rosetta gami B (DE3) E. coli cells (Novagen) that were then inoculated into 200 ml of
LB medium containing carbenicillin (100 μg/ml) and chloramphenicol (34 μg/ml) and
grown at 37°C with shaking at 250 rpm until the optical density at 600 nm reached 0.4 to
0.6. Protein expression was induced by the addition of IPTG (final concentration, 1 mM),
and cells were then incubated for 20 h at 20°C with shaking at 250 rpm. Cells were
harvested in four 50-ml tubes by centrifugation at 5,000 rpm and 4°C for 20 min (using a
Hettich Universal 320 centrifuge and a model 1617 rotor). Cell pellets were frozen and
stored at −80°C before undergoing further processing. The cell pellet was resuspended in
3 ml of native lysis buffer (20 mM Tris-HCl, 500 mM NaCl, 20 mM imidazole, 0.15%
Triton X-100 [pH 8.0], and 250 μl of lysozyme at 1 mg/ml). The cells were lysed by
sonication on ice as described earlier and centrifuged at 18,000 rpm for 45 min. The
supernatant containing the soluble fraction was retained for affinity purification. A 1-ml
volume of nickel-chelating resin suspension (G-Biosciences) was packed in a MicroSpin
column and equilibrated with 600 μl of native lysis buffer. The supernatants containing
the hexahistidine-tagged recombinant antibodies were loaded onto the equilibrated 1-ml
Ni2+-NTA spin column and centrifuged (using a Hettich 320R Universal centrifuge and a
1689-A rotor) at 1,600 rpm for 5 min. The flowthrough was collected and the Ni2+-NTA
column washed two times with 600 μl of wash buffer (20 mM Tris-HCl, 500 mM NaCl,
20 mM imidazole, pH 8.0) at 2,900 rpm for 2 min. The bound recombinant antibodies
were eluted into 100-μl fractions using 500 μl of elution buffer (20 mM Tris-HCl, 500
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mM NaCl, 500 mM imidazole, pH 8.0) at 2,900 rpm for 2 min, and the purified scFv was
stored at 4°C.
Functional assays
Recombinant scFv binding to MopB was examined by Western blot, ELISA, and
immunofluorescence analysis. The scFv antibody binding to recombinant MopB was
detected using the DVPDYAS peptide tag and a secondary recombinant scFv antibody
with a (Gly4Ser)3 linker based on the VH and VLsequences of the mouse 26/9 antiDVPDYAS monoclonal antibody (12) fused to alkaline phosphatase (phoA) (46) (antiHA scFv-AP) in both the ELISA and Western blot analysis. ELISA with either fulllength mature or truncated MopB was performed as described earlier with a modification
using 5% (wt/vol) milk–Tris-buffered saline (TBS) containing 0.1% NaN3 as a negative
control. Purified antibodies, selected scFv antibody for MopB, and negative-control antiNANP repeat scFv based on a 2A10 MAb diluted 1 in 10 using TBS-NaN3 were
incubated for 6 h at 8°C. After washing with TBS containing 0.05% Tween-20 (TBSTNaN3), anti-HA scFv-AP antibody (diluted 1:10 in 1% [wt/vol] milk–TBS–NaN3) was
added and the mixture was incubated overnight at 8°C, washed as before, and developed
with p-nitrophenyl phosphate as described earlier.
For the Western blot analysis, recombinant MopB proteins were resolved by SDSPAGE as described earlier and blotted onto a polyvinylidene fluoride (PVDF) membrane,
blocked in 5% (wt/vol) milk–TBS at room temperature for 1 h, and then incubated with
the scFv 4XfMopB3 as the primary antibody (diluted 1:10 in 1% [wt/vol] milk–TBS) for
6 h at 8°C. After washing with TBST incubated with the secondary antibody, anti-HA
scFv-AP antibody (diluted 1:10 in 1% [wt/vol] milk–TBS–0.1% NaN3) was added and
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the mixture was incubated at room temperature for 1 h on a rocking platform followed by
washing as before and a final rinse with TBS (5 min) prior to the addition of BCIP-NBT
substrate as described earlier.
Heat-killed X. fastidiosa was air dried on glass slides and blocked with 2%
(wt/vol) milk–PBS for 30 min. Purified scFv antibodies (selected scFv antibody for
MopB and negative-control scFv 2A10 antibody) were diluted 1 in 10 with 1% (wt/vol)
milk–PBS. The slides were incubated with XfMopB3 (anti-MopB), 2A10 (nonspecific),
or no scFv for 1 h. After washing with PBS, anti-polyhistidine-fluorescein isothiocyanate
(FITC) conjugate (AbCam, United Kingdom) (diluted 1:10,000 in 1% [wt/vol] milk–
PBS) was added. The slides were incubated for 1 h at the ambient temperature in the
dark. Slides were washed with PBS and viewed under oil immersion on an Axioscop 50
fluorescence microscope (Zeiss). Images were captured using a charge-coupled-device
(CCD) camera (PowerShot digital camera; Canon) and AxioVision software (Zeiss).
Nucleotide sequence accession numbers
The GenBank accession numbers for the 4XfMopB1 and 4XfMopB3 scFv's
are JQ606804 and JQ606805, respectively.

Results
MopB bioinformatic analysis
The X. fastidiosa Temecula1 MopB protein sequence downloaded from the NCBI
database was analyzed using SIG-PRED to predict the putative signal sequences, and
Met1-Ala36 and Met15-Ala36 were identified (Fig. 3A). The β-barrel transmembrane
domain identified using PRED TMBB was determined to be between Trp43 and Tyr177.
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FIG 3 The amino acid sequence of Xylella fastidiosa Temecula1 MopB and the predicted model for
the B-barrel outer membrane domain. (A) The putative leader sequence starting at Met1 is indicated
with black underlining; a shorter potential leader sequence starting at Met15 (previously identified by
Bruening et al.) (8) is indicated with a black line over the sequence and gray highlighting. The arrow
between Ala36 and Gln37 denotes a signal peptide cleavage site, gray denotes periplasmic regions, blue
denotes membrane-spanning regions, and red denotes surface-exposed loops. The yellow highlighted
region corresponds to the truncated MopB. The sequence scored a value of 2.929, which is lower than
the threshold value of 2.965. The difference between the measured value and the threshold indicates the
possibility of the protein being an outer membrane protein. (B) A two-dimensional figure of the
predicted MopB transmembrane β-barrel with the protruding surface-exposed loops generated using
PRED TMBB. The amino acid numbers of the beginning and end of the β-strand traversing the outer
membrane are in gray.
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A two-dimensional representation of the result shows the exposed loops, with the last
loop being the longest (Fig. 3B). The recombinant mature and truncated MopB proteins
expressed in pSANG 10-3F were predicted to have a pI of 6.36 and molecular mass of
42.98 kDa and a pI of 6.79 and molecular mass of 24.64 kDa, respectively.
Expression and purification of the full-length mature and truncated MopB proteins
The genes encoding full-length mature Met-Ala36-Asn389 and truncated MetAla36-Gly252 MopB from X. fastidiosa were PCR amplified and cloned into the
pSANG10-3F vector and verified by DNA sequencing. Protein analysis by SDS-PAGE
revealed abundant full-length and truncated MopB proteins at 3 h postinduction with

FIG 4 (A) SDS-PAGE analysis of mature full-length MopB expression and purification under
denaturing conditions. Lane 1, protein molecular mass markers; lane 2, noninduced; lane 3, induced;
lane 4, final wash; lanes 5 and 6, elutions 2 and 3. (B) SDS-PAGE analysis of truncated MopB
expression and purification under denaturing conditions. Lane 1, protein markers; lane 2, uninduced;
lane 3, induced; lane 4, soluble fraction; lane 5, flowthrough; lane 6, final wash; lanes 7 to 10, elutions
1 to 4.

IPTG at 37°C. The SDS-PAGE results indicated proteins with an apparent molecular
mass of about 43 kDa for full-length MopB and 25 kDa for truncated MopB (Fig. 4A and
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B, respectively). The recoveries of recombinant mature and truncated MopB proteins
were estimated to be approximately 50 mg/liter of culture.
Serum ELISA and dot blot analysis
The ELISA performed with immobilized recombinant truncated MopB protein
and a 1/20,000 dilution of sera from bleed 3 of the mice immunized with whole heatkilled X. fastidiosa indicated that 4 of 5 mice produced antibodies that recognized the
recombinant surface-exposed portion of MopB with little or no cross-reactivity with the
BSA control protein (Fig. 5A). The immune sera from bleed 3 were also evaluated in a
dot blot analysis using whole intact bacteria of E. coli and the X. fastidiosa Temecula1
strain (Fig. 5B). Mouse sera 1, 2, 4, and 5 had clear antibody binding to X. fastidiosa at a
dilution of 1/20,000, whereas mouse 3 serum did not. The antibody activity against milk
proteins was absent or very weak in mouse sera 2 and 4.
Mouse immunoglobulin library assembly and ribosome display
The amounts of total RNA isolated from the mice ranged from 200 to 50 μg with
various degrees of purity as shown in Table S2 in the supplemental material, providing
ample material for the subsequent cDNA reactions. The immunoglobulin libraries were
assembled as outlined in the schematic; the PCR amplification results and steps of the
library construction performed using mouse 4 spleen-derived cDNA are shown in Fig. 1.
Mouse Vk6 and VH4 and -8 were present at lower levels; all other immunoglobulin
families were readily amplified. The final DNA template encoding the library flanked by
a T7 site and a synthetic mouse kappa constant chain was used in an in vitro ribosome
display with a single selection step wittruncated MopB as outlined in Fig. 2. The affinityenriched mRNAs were amplified by RT-PCR and cloned into pCRII-TOPO vector. From
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FIG 5 Mouse immune serum evaluation by ELISA and immuno-dot blot analysis. (A) Mouse 1 to 5
sera from bleed 3 diluted 1/20,000 in the ELISA performed with truncated MopB (10 μg/ml) or BSA
(10 μg/ml) and h blank, rabbit anti-mouse (1/20,000) plus anti-rabbit alkaline phosphatase, and antirabbit alkaline phosphatase (1/40,000) without anti-mouse antibody. (B) Immuno-dot blot screen with a
1/20,000 dilution of bleed 3 sera from mice 1 to 5 on 5% (wt/vol) milk protein control or 5 μl of E.
coli or X. fastidiosa spotted directly onto nitrocellulose strips and probed with rabbit anti-mouse
alkaline phosphatase and developed with NBT-BCIP.
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FIG 6 Functional analysis of 4XfMopB3 HA scFv by ELISA and Western blot analysis. (A) The
ELISA with full-length and truncated MopB and 5% milk protein as a control. 2A10 scFv expressed in
pAHAHis control antibody (against NANP repeat) was used as an irrelevant negative-control scFv. The
detection of anti-HA alkaline phosphatase without a first antibody and detection of the substrate alone
were used as additional controls. (B) MopB Western blot analysis using 4XfMopB3 HA scFv with
mature full-length and truncated MopB on nitrocellulose membrane and detected with anti-HA alkaline
phosphatase.
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approximately 100 white colonies, 4 were randomly selected to prepare plasmids for
sequencing. Three with confirmed intact in-frame VL and VH combinations were
subcloned into pAINFHis for scFv expression and characterization (4XfMopB1,
4XfMopB2, 4XfMopB3). Analysis of the variable region sequences (see Table S3 in the
supplemental material) shows that different gene segments of the antibody sequences are
present in the selected recombinant antibody clones. 4XfMopB3 scFv antibody detected
recombinant mature and truncated MopB in the Western blot analysis and ELISA (Fig.
6), whereas clone 4XfMopB1 detected MopB in the Western blot analysis only (data not
shown). Furthermore, the Xf4MopB3 scFv was used to image X. fastidiosa by
immunofluorescence microscopy as shown in Fig. 7.

Discussion
Investigations of plant-pathogen and vector-pathogen interfaces in PD would be
greatly facilitated with the availability of highly specific monoclonal antibodies.
Although it is possible to use conventional hybridoma technology (30) to obtain
monoclonal antibodies and then clone and reassemble the corresponding antigen binding
site genes, recombinant antibody display technology is a more cost-effective option for
the nonspecialized laboratory, requiring general molecular biology skills, reagents, and
techniques to build and access antibody libraries. Moreover, genetically encoded scFv's
are amenable to further engineering to optimize the desired characteristics, such as
affinity, specificity (21), or formation of multimers (25) or as fluorescent molecules
(34, 35). The use of a complex immunogen (i.e., whole bacteria) with a mixture of
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FIG 7 Immunofluorescence detection of X. fastidiosa with Xf4MopB3 scFv. Panels A, C, and E were
viewed with bright-field microscopy and B, D, and F with fluorescence microscopy. (A and B) X.
fastidiosa with primary 4XfMopB3 scFv probed with secondary anti-polyhistidine FITC. (C and D) X.
fastidiosa with primary anti-NPNA scFv probed with secondary anti-polyhistidine FITC. (E and F) X.
fastidiosa probed with primary anti-polyhistidine FITC only. The size bars shown in panels A and B are
5 μm.
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antibodies against a mixture of targets (on the cell surfaces) (5) results in combinatorial
complexity and invariably requires deconvolution at some point (50). When initially
validating a technique, a simpler approach is to anchor one component and search
through a complex mixture of potential partners. In this study, we assembled
combinatorial libraries of recombinant antibodies from mice immunized with whole heatkilled X. fastidiosa. To deconvolute the mixture, we chose a surface-exposed molecule,
MopB, as bait.
Although the role of MopB in X. fastidiosa is not known, it is an abundant surface
protein and may potentially be a target for bacterial agglutination via engineered
recombinant antibodies. Earlier studies that attempted to isolate natural MopB and to
make recombinant MopB protein had met with limited success (7, 8). An in silico
analysis of the target identified key features that assisted in the design of an appropriate
recombinant bait molecule for use in antibody selection. MopB has a characteristic signal
leader sequence (Met15-Ala36) with a classical cleavage motif, Ala Ser Ala, followed by
a transmembrane β-barrel (with surface-exposed loops), Trp43-Tyr177, and a periplasmic
domain, Arg178-Asn389 (Fig. 3). The protein is extremely toxic to the heterologous
host E. coli when inserted into the outer membrane by the use of either its natural leader
sequence or an alternative such as ompA. A leaderless construct results in proteins not
traversing or inserting in the inner membrane but being retained in the bacterial
cytoplasm and aggregating due to the hydrophobic nature of the transmembrane β-sheets.
Full-length mature (43-kDa) MopB proteins and truncated (25-kDa) recombinant MopB
proteins were both efficiently expressed without a leader sequence. Extraction using
denaturing conditions released the recombinant MopB into the soluble fraction. SDS-
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PAGE analysis tracking the expression and purification revealed that the recombinant
proteins were enriched, and the major products eluting from the affinity resin
corresponded to the predicted sizes for the mature and truncated MopB (Fig. 4), with a
yield of ∼50 mg/liter of bacterial culture.
Sera (diluted 1/20,000) from X. fastidiosa-immune mice 1, 2, 4 and 5 had activity
against truncated MopB protein and X. fastidiosa in the ELISA and immuno-dot blot
analysis, respectively. Mouse 3 serum produced the lowest signal in both assays (Fig. 5).
The very high dilution used in both the evaluations of the sera suggests a very robust
response to the whole-bacterial-antigen preparation.
Five antibody libraries were assembled following the steps outlined in Fig. 1, and
the mouse 4 DNA antibody library was used in the subsequent selection procedure. After
a single enrichment step using ribosome display, scFv's specific for MopB were readily
isolated. This rapid enrichment may be a common feature of antibody libraries
constructed from intentionally immunized or naturally immune sources and is in
agreement with our findings determined using antibody ribosome display to access
human scFv's against HIV-1 gp120 constructed from an HIV-1-positive donor (48),
where only a single round of selection was required.
One scFv, 4XfMopB3, recognized the mature and truncated recombinant MopB
proteins in both the ELISA and Western blot analysis (Fig. 6) and heat-killed X.
fastidiosa by IFA (Fig. 7), suggesting that the epitope is nonconformational and possibly
one of the three predicted loops exposed on the surface of the bacteria. These results
provide evidence that immunization with whole heat-killed X. fastidiosa clearly induces
antibodies against surface-exposed antigenic molecules such as MopB, indicating that the
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mild heat treatment used to kill the bacteria preserved the surface-accessible protein
immunogenicity. We speculate that the immune sera may also have contained antibodies
against other putative surface-exposed molecules possibly associated with attachment in
either the GWSS or theV. vinifera grapevine (31).
The in vitro anti-X. fastidiosa scFv libraries generated in this study and the
strategy for preparing recombinant putative membrane proteins provide approaches for
rapidly discovering additional scFv's against surface components involved in aggregation
(19) and/or motility (15, 24, 33). The anti-MopB or other anti-X. fastidiosa scFv
molecules may also have use in diagnostic applications for pathogen surveillance and
could be assembled with in-built fluorophores as described recently (34, 35).
With the availability of genetically encoded molecules that target the surface of X.
fastidiosa, alternative ways to investigate the biology of X. fastidiosa host-vector
interactions may be explored to develop interventions. One such approach is
paratransgenesis, which in concept involves the genetic manipulation of a vector's
naturally occurring microorganisms such as bacteria, fungi, or viruses to compromise
competence to transmit a particular agent.
Engineering symbiotic bacteria to express and secrete recombinant molecules
inside an arthropod was initially demonstrated using the bacterium Rhodococcus
rhodnii to express cecropin (16) in the kissing bug Rhodnius prolixus, the vector of
Chagas' disease, and subsequently to express an scFv (17). Recently, scFv's that
target Trypanosoma cruzi epimastigote glycans have been developed for use in this
paratransgenic application (34). This strategy may also be implemented with symbionts
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or commensal organisms of the GWSS (40). Alternatively, other “Trojan horse” vehicles
may be developed.
Recently, an scFv against a Plasmodium falciparum sporozoite surface protein
isolated from a malaria-immune individual (10) and shown to inhibit sporozoite invasion
of human hepatocytes (9), has been used to reduce P. falciparum sporozoite levels
in Anopheles gambiae via an engineered entomopathogenic fungus (18), basically using
an infection to fight an infection (41). In the malaria study, the recombinant antibody
PfNPNA-1 targeted a conserved surface-accessible repetitive target on the highly
abundant circumsporozoite protein and was engineered to agglutinate the parasite,
preventing migration to and invasion of the salivary gland. Such an approach is
independent of disrupting host cell-specific interactions and may be a general strategy
against targets that are present at high density on the pathogen surface. Recombinant
antibodies against MopB and other abundant surface-exposed molecules on X.
fastidiosa could also be engineered in a similar way to agglutinate the bacteria and
evaluated in the GWSS via paratransgenic organisms such as engineered commensals or
symbionts or by infection with Metarrhizium spp. or Beauvaria bassiana, providing
novel alternative platforms to investigate in the control of PD.
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Chapter 5: Conclusions
Paratransgenic control is a Trojan Horse strategy, which has been designed to
control various vector borne diseases (Durvasula et al., 1997; Wang et al., 2012). We
have utilized the same strategy to control Pierce's disease (PD) of grapevines, a disease
caused by a bacterium, Xylella fastidiosa and transmitted by the glassy-winged
sharpshooter (GWSS, Homalodisca vitripennis). Based on its acquisition and persistence
within the sharpshooter foregut, we selected Pantoea agglomerans E325 as the
paratransgenic control agent to block X. fastidiosa transmission. The Environmental
Protection Agency (EPA) has already approved use of P. agglomerans E325 to control
fire blight of apples and pears. We genetically modified P. agglomerans to express
enhanced green fluorescent protein (EGFP) to study the interaction of P. agglomerans
with H. vitripennis. H. vitripennis was able to acquire EGFP-expressing P. agglomerans
from the artificial feeding system (AFS) and P. agglomerans persisted within the GWSS
foregut for 15 days (Chapter 2).
Different paratransgenic models have been conceived and a decrease in vector
competence to carry parasites such as Trypanosoma cruzi and Plasmodium sp. was
achieved under lab conditions (Durvasula et al., 1997; Wang et al., 2012). However,the
paratransgenic strategy is still a lab concept and field application of any of the
paratransgenic agents yet to be realized, mainly due to the absence of a safe delivery
system. We developed calcium-alginate based microparticles for field application of
genetically modified P. agglomerans. These microparticles were designed to open up
under high hydraulic pressure. When the GWSS fed on plants painted with P.
agglomeran-containing microparticles, these microparticles swell due to pressure exerted
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by the xylem flow resulting in bacterial release within the sharpshooter foregut (Chapter
2). We engineered microparticles with different alginate concentrations (1%, 2%, and
3%). Microparticles engineered using 1% alginate showed promise as 51.8% GWSSs
were able to acquire EGFP-expressing P. agglomerans from plants painted with EGFPexpressing P. agglomerans-containing microparticles. These microparticles provide a
physical barrier between the bacteria and the outer environment, which will help to
decrease environmental contamination and horizontal gene transfer. Additionally,
bacteria present within microparticles were able to withstand UVC radiation and
desiccation. This resistance is significant and a necessity to accomplish paratransgenic
control of PD as direct sunlight in the grape fields results in very dry conditions and also
imposes a high dose of UV radiations (Chapter 2).
Antimicrobial peptides (AMPs) are small proteins, which are amphiphatic in
nature. These molecules in general, make holes in the cell membrane of bacteria and
other microorganisms and kill them. We tested toxicity of two AMPs, melittin and
scorpine like molecule (SLM), against X. fastidiosa and P. agglomerans. Both these
AMPs exhibited higher toxicity against X. fastidiosa in comparison to P. agglomerans
and we chose them to be delivered via P. agglomerans (Chapter 3). Using the
Escherichia coli hemolysin secretion system we genetically modified P. agglomerans to
express melittin and SLM. We confirmed presence of AMPs in spent medium through
Western blot (Chapter 3). Both melittin and SLM-expressing P. agglomerans lines were
tested for their efficacy to block X. fastidiosa acquisition and transmission by H.
vitripennis. We observed a decrease in acquisition and abolishment of transmission of X.
fastidiosa by paratransgenic H. vitripennis carrying melittin or SLM-expressing P.
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agglomerans lines (Chapter 3). Presence of AMPs within insect gut resulted in
decreasing vector competence was confirmed by detecting melittin and SLM in insect
bodies via Western blot (Chapter 3). This is first time, when paratransgenic control has
been shown to prevent experimental transmission of a plant disease. Further, this is the
first time, when not only decrease in acquisition, but abolishment of pathogen
transmission has been achieved using paratransgenic insects.
To control PD transmission we used AMP-expressing P. agglomerans lines.
Though the AMPs are very potent molecules, they lack specificity. We can increase the
safety of paratransgenic control by utilizing molecules with higher specificity, such as
single chain atibodies (scFv). To achieve this goal we engineered scFvs specific to X.
fastidiosa surface protein mopB (Chapter 4). We used ribosomal display to engineer
scFvs against mopB. To produce scFv we harvested the spleens from the mice that were
previously injected with heat killed X. fastidiosa (Chapter 3). In parallel, we expressed
and purified mopB with histidine tag in E. coli cells. We utilized purified mopB protein
to select for antibodies that bound to mopB protein. Using ribosomal display technology
we were able to engineer scFvs, which can bind to purified mopB as well as to whole X.
fastidiosa cells (Chapter 4).
This dissertation is focused on achieving paratransgenic control of PD using P.
agglomerans E325 as a delivery vehicle. We developed microparticles for field release of
bacteria to limit the environmental contamination, horizontal gene transfer and site
specific release of payload. We engineered P. agglomerans lines that rendered H.
vitripennis incompetent of transmitting X. fastidiosa. We also engineered scFv specific to
mopB surface protein of X. fastidiosa.
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We believe that in the future paratransgenic control will be used in the field to
control PD and this model will act as a framework to test other paratransgenic models.
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